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Summary
Transcription of protein-coding genes by RNA polymerase (Pol) II begins with the assembly of
an initiation complex at the promoter. As the RNA is synthesized, initiation factors dissociate
from Pol II, and elongation factors are recruited. Whereas Pol II is unphosphorylated during
initiation, it is phosphorylated at its C-terminal repeat domain (CTD) during elongation. The
CTD forms a ﬂexible extension of Pol II that consists of 26 (yeast) or 52 (human) heptapeptide
repeats of the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. Changes in CTD
phosphorylation coordinate the recruitment of mRNA transcription and processing factors
to Pol II. Ser5 phosphorylation recruits the mRNA 5´ capping machinery near the promoter,
whereas Ser2 phosphorylation recruits mRNA 3´ processing and termination factors near the
polyadenylation (pA) site.
This work presents genome-wide chromatin-immunoprecipitation (ChIP) occupancy proﬁles
for Pol II, its phosphorylated forms and transcription factors in proliferating budding
yeast Saccharomyces cerevisiae (S. cerevisiae) cells. Pol II exchanges initiation factors
for elongation factors during a 5´ transition that is completed about 150 nucleotides (nt)
downstream of the transcription start site (TSS). The resulting elongation complex is
composed of all elongation factors at all genes and shows high levels of Ser7 and Ser5
phosphorylation on the CTD. Ser7 and Ser5 phosphorylation levels then decrease over the
transcribed region, whereas Tyr1 and Ser2 phosphorylation levels increase and saturate
at 6001,000 nt downstream of the TSS. Elongation complexes disassemble in a two-step
3´ transition. Bur1, Ctk1, Paf1 and Spt16 exit upstream of the pA site, whereas Elf1, Spt4,
Spt5, Spt6 and Spn1 exit downstream. Peak levels for mRNA 3´ processing and termination
factors are observed downstream of the pA site.
After deﬁning the transitions in Pol II complex composition along genes, we further
elucidated the underlying molecular mechanisms that are responsible for transcription factor
exchange. First, we show that during the 5´ initiation-elongation transition the early Pol II
elongation factor Spt5 contributes to gene recruitment of the mRNA capping enzymes Cet1,
Ceg1 and Abd1. Genome-wide occupancy for Cet1 and Ceg1 is restricted to the TSS,
whereas occupancy for Abd1 peaks ∼110 nt downstream, and occupancy for the cap-binding
complex (CBC) rises subsequently. Abd1 and CBC are shown to be important for recruitment
of the kinases Ctk1 and Bur1, which promote elongation and capping enzyme release. Second,
we show that Tyr1 phosphorylation of the CTD impairs recruitment of termination factors
during elongation. About 180 nt upstream of the pA site, Tyr1 phosphorylation levels drop,
whereas Ser2 phosphorylation levels remain high. This enables recruitment of termination
factors Rtt103 and Pcf11, resulting in mRNA 3´ processing and transcription termination.
Taken together, our results point to a general Pol II transcription complex that mediates
transcription and mRNA processing at all actively transcribed Pol II genes in yeast. At
both ends of genes this complex undergoes uniform transitions that are independent of
gene length, gene type or expression level. Moreover, our results indicate that mRNA
5´ cap completion underlies the initiation-elongation transition and triggers productive
Pol II elongation and that CTD Tyr1 dephosphorylation underlies the elongation-termination
transition and triggers mRNA 3´ processing and termination.
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Part I
Introduction
Transcription represents one of the most fundamental biological processes, during which DNA is
transcribed into RNA by DNA-dependent RNA polymerases [229]. In eukaryotes exist three nuclear
RNA polymerases: RNA polymerase (Pol) I, Pol II, and Pol III [36]. Pol I synthesizes most of the
ribosomal RNAs (rRNAs), whereas Pol III synthesizes transfer RNAs (tRNAs), 5S rRNA, and
other small RNAs. Pol II produces messenger RNAs (mRNAs), as well as several non-coding
RNAs, including small nuclear RNAs (snRNAs), and small nucleolar RNAs (snoRNAs). Recent
genome-wide transcriptome analyses revealed that Pol II transcription is pervasive and not limited
to protein-coding and sno/snRNA genes [89]. These studies revealed that up to 80% of the
yeast [44, 159] and human [12, 102] genomes are transcribed, identifying hundreds of novel non-coding
RNAs. In yeast, stable unannotated transcripts (SUTs, [242]) exist stably in cells, while cryptic
unstable transcripts (CUTs, [242]) and Xrn1-sensitive unstable transcripts (XUTs, [223]) are rapidly
degraded after synthesis. To what extent these novel transcripts or their synthesis are biologically
functional [228], or whether the majority simply accounts for transcriptional noise [211], is still
unclear.
Pol I, II and III are multi-subunit enzymes comprised of a conserved ten-subunit core and up to
seven addtional subunits [36]. Pol II is composed of 12 subunits, termed Rpb1  12, with Rpb1
being the largest. Rpb1 has evolved a highly repetitive C-terminal domain (CTD) which is unique
to Pol II and plays a central role in transcription mediated by its dynamic phosphorylation [77].
1 mRNA synthesis by RNA polymerase II
The ﬁrst step of Francis Crick's central dogma of molecular biology [39], the transcription of protein-
coding genes into mRNA, is catalyzed by RNA polymerase (Pol) II with the help of many auxiliary
factors in a repetitive, cyclic process, named the transcription cycle (Section 1.1). In eukaryotes,
the genetic information contained in the DNA is ﬁrst transferred to pre-mRNA that must be further
co-transcriptionally processed by RNA processing factors (Section 1.2). Correct processing and
export to the cytoplasm enable translation of the mature mRNA by the ribosomes.
1.1 The RNA polymerase II transcription cycle
The main phases of the Pol II transcription cycle consist of initiation and promoter clearance (Sec-
tion 1.1.1), elongation (Section 1.1.2), as well as termination and re-initiation (Section 1.1.3) of
transcription.
1.1.1 Initiation and promoter clearance
Transcription of protein-coding genes by Pol II begins with the assembly of a pre-initiation
complex (PIC) at the promoter. The PIC consists of general transcription factors (GTFs) that
recognize core promoters and recruit Pol II [71, 205]. Moreover, GTFs interact with coactivators
like Mediator or SAGA to modulate transcription. The GTFs TBP, TFIIA and TFIIB form a
complex with promoter DNA. TFIIB, along with TFIIF, is critical for subsequent Pol II recruitment
and positioning of the promoter DNA above the Pol II cleft. The remaining factors, TFIIE and
TFIIH are required for separation and stabilization of promoter DNA strands, leading to formation
of the open complex that allows the single-stranded DNA template to enter the active site of
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Figure 1: Structure of yeast Spt4-5
bound to Pol II. The complete yeast
Pol II elongation complex with bound
Spt4-5 is viewed from the back [141].
Pol II and Spt4-5 are shown as molecular
surfaces with key domains highlighted
in color. Exiting RNA, the C-terminal
KOW domains and C-terminal repeat re-
gion of Spt5 (CTR), and the Pol II largest
subunit C-terminal domain (CTD) ex-
tend towards the same side around the
Rpb4/7 subcomplex.
Pol II [105]. The subunit of TFIIH that is required for the structural remodeling of the PIC
during this process is Rad25 (human XPB), an ATP-dependent DNA helicase. The complex then
scans for the transcription start site (TSS) downstream and initiates transcription, leading to the
initially transcribing complex (ITC) [26]. Recent structural data propose additional roles for TFIIB
in DNA opening and start site recognition via the `B-linker' and `B-reader' domains [115]. The ITC
is unstable and the transition into a stable elongation complex is prone to abortive initiation and
release of short RNAs [137]. As the nascent RNA grows, the complex stabilizes, disengages from
promoter DNA, and initiation factors dissociate from Pol II. This process is referred to as promoter
clearance or promoter escape [137]. Subsequently, elongation factors are recruited [167, 168, 176].
The initiation-elongation transition begins when the nascent RNA grows to about 12 nucleotides (nt),
which releases initiation factor TFIIB [169, 194]. Release of initiation factors frees the Pol II clamp
domain, which can then bind the conserved elongation factor Spt5 [65, 141] (Figure 1).
1.1.2 Elongation
After the transition into a productively transcribing elongation complex (TEC), Pol II is assisted
by a number of proteins (elongation factors, EFs) to facilitate eﬃcient gene transcription [195, 206].
Some of these EFs can inﬂuence the rate and processivity of Pol II directly (e.g. TFIIS [104]),
whereas others are needed to transcribe eﬃciently through the chromatin environment (see below).
Furthermore, some EFs are needed to facilitate co-transcriptional recruitment of RNA processing
factors (see below and Section 1.2). The major EFs in S. cerevisiae which are of particular interest
for this work are listed in Table 1 and are further described in the following paragraphs:
The conserved elongation factor Spt5 The essential elongation factor Spt5 [236], which
directly binds the Pol II clamp domain [65, 141] (Figure 1) and forms the Spt4-Spt5 complex [75]
(human DSIF, [227]), is of particular importance as it is the only known Pol II-associated factor
that is conserved in all three kingdoms of life [231]. The core function of Spt4-5 is to stimulate
transcription elongation and Pol II processivity [74]. Spt5 copuriﬁes with over 90 yeast proteins that
are involved in transcription elongation, RNA processing, transcription termination, and mRNA
export [130]. Eukaryotic Spt5 possesses a repetitive C-terminal region (CTR) [215, 254] that has
16
Factor Function
Bur1 Cyclin (Bur2)-dependent kinase; phosphorylates Pol II CTD and Spt5 CTR
Ctk1 Catalytic subunit of CTD kinase I (CTDK-I); phosphorylates serine 2 on the Pol II CTD
Elf1 Implicated in maintaining proper chromatin structure during elongation
PafC Modulates H2B monoubiquitination and H3K4 methylation; recruits Set1 and Set2
Spn1 Associates with Spt6
Spt4-5 Stimulates elongation and capping; suppresses early transcript termination
Spt6 Stimulates elongation; histone chaperone activity; modulates chromatin structure
Spt16 Facilitates elongation through chromatin; histone chaperone activity
Table 1: Transcription elongation factors of RNA polymerase II in S. cerevisiae.
See text for references and details. This list contains only elongation factors that are further investigated in
this work (Section 6). For a complete list of elongation factors and their functions refer to [195, 206].
been shown to act as a platform for recruiting accessory factors to elongating Pol II. Spt5 interacts
with capping enzymes [130, 173, 198, 230] and the CTR recruits the Paf complex [132, 254] (see
below). Spt4-5 also interacts with the elongation factor and histone chaperone Spt6 to modulate
chromatin structure [75, 216] (see below).
Elongation through chromatin requires the Paf complex, FACT, and Spt6 Chromatin
is a nucleoprotein structure built from nucleosomes that contain 147 bp of DNA wrapped around an
octamer of histone proteins [126]. The histone octamer consists of two copies of each histone protein
H2A, H2B, H3, and H4. The chromatin architecture represents a barrier to Pol II transcription, and
thus needs to be overcome during transcription elongation with the help of auxiliary factors.
The Paf complex (PafC), consisting of Paf1, Ctr9, Cdc73, Rtf1 and Leo1 in yeast, is a conserved
elongation factor [90, 221]. Together with Spt4-Spt5, PafC is involved in recruitment of chromatin
factors during early transcription elongation. These factors include the histone chaperones Spt6
and FACT (facilitates chromatin transcription), as well as the histone H3K4 methyltransferase Set1
complex (COMPASS). The FACT complex (consisiting of Spt16 and Pob3 in yeast) [10, 166, 197, 237]
and Spt6 [16, 101], help Pol II transcribe through nucleosomes by displacing histones and rapidly
reassembling them after Pol II passage. Maintaining proper chromatin structure during elongation
is important, as mutations in FACT or Spt6 lead to transcription initiation from cryptic start sites,
which are exposed within gene bodies when redeposition of histones fails [101, 142]. Spt6 was
identiﬁed in the same genetic screen as Spt4-5 and Spt16 [236], and physically interacts with Pol II,
as well as elongation factors Spn1, Spt5, and Spt16 [117, 130, 216].
Methylations of histones H3K4 and H3K36 by the methyltransferases Set1 and Set2, respectively,
represent elongation-related histone modiﬁcations observed at actively transcribed genes [177, 207].
During early elongation Set1 is recruited to the serine 5 phosphorylated CTD of Pol II, whereas
Set2 is recruited later during elongation via binding also to the serine 2 phosphorylated CTD (see
Section 1.2.1 for details). Proper H3K4 and H3K36 methylation patterns are important to recruit
further histone acetylation and chromatin remodeling complexes during elongation [126, 207].
Pol II CTD kinases Bur1 and Ctk1 Diﬀerential phosphorylation of the Pol II CTD during the
transcription cycle plays a key role in co-transcriptional coupling of pre-mRNA processing [77, 86,
250] (Section 3). Responsible for the changing phosphorylation patterns of the CTD are CTD kinases
and phosphatases, many of which act during transcription elongation. Serine 2 phosphorylation of
the CTD represents the hallmark of productively elongating Pol II and is catalized by the Bur1 [182]
and Ctk1 [28] kinases. Dynamic phosphorylation of the CTD as well as detailed information on CTD
function are discussed in Section 1.2.1.
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1.1.3 Termination and re-initiation
Transcription termination of protein-coding genes requires several protein complexes to bind to Pol II
as well as to speciﬁc sequences in the nascent mRNA when the transcription complex reaches the
polyadenylation (pA) site [138, 155, 189]. The pA site marks the point of RNA 3´-cleavage and
polyadenylation (see Section 1.2.4 for details), but transcription continues beyond this site until
termination where Pol II is released from the DNA template over a range of about 200 bp (1500 bp
in humans) downstream. Initially, two models have been proposed how Pol II iss dismantled from
the DNA during termination. In the `anti-terminator' model, transcription of the pA site triggers
a change in the Pol II machinery that allows for termination [193]. In the `torpedo' model, pA-
dependent RNA cleavage results in a new RNA 5'-end that is recognized by the Rat1/Rai1/Rtt103
exonuclease complex that degrades nascent RNA and triggers termination [109, 233]. However,
recent data indicate that transcription termination may be a combination of both models [234].
Transcription is a cyclic process that can be initiated again after termination either by recruitment
of the complete transcription machinery to the gene promoter or by re-initiation. Re-initiation is
facilitated by a subset of initiation factors, including TFIIA, -D, -E, -H and Mediator, which remain
bound to the promoter after the ﬁrst round of trancription initiation, forming a so-called scaﬀold
complex [247]. This scaﬀold complex then enables rapid PIC formation during successive rounds of
transcription.
1.2 Coordination of transcription and pre-mRNA processing
Processing of the newly transcribed pre-mRNA occurs co-transcriptionally and starts as soon as
the nascent transcript emerges from the RNA exit tunnel of Pol II [37, 139]. The CTD of
Pol II plays a pivotal role in this process (Section 1.2.1, Figure 2). It couples the three main
pre-mRNA processing events, which are 5'-capping (Section 1.2.2), splicing (Section 1.2.3) and
3'-end formation (Section 1.2.4) to the three main phases of the transcription cycle (Section 1.1),
initiation, elongation and termination, respectively (Figure 3) [77, 86, 250]. This spatio-temporal
coupling allows pre-mRNA processing events to occur in an ordered manner. Moreover, pre-mRNA
processing events are interdependent, as capping is required for splicing [202], and splicing enhances
3'-end formation [135, 164] and vice versa [222].
1.2.1 The CTD code
A unique feature that distinguishes Pol II from the other two eukaryotic polymerases is the presence
of an extended carboxy-terminal domain (CTD) at Rpb1, the largest of the 12 subunits of Pol II [36].
The CTD consists of 26 (yeast) or 52 (human) highly conserved heptad repeats of the consensus
Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. In an extended conformation the CTD has a length of over
four times the diameter of the core polymerase (Figure 2A). The CTD becomes diﬀerentially
phosphorylated and dephosphorylated at ﬁve of the seven residues (Tyr1 (Y1), Ser2 (S2), Thr4
(T4), Ser5 (S5), Ser7 (S7)) in coordination with the transcription cycle (Figure 2B) [77, 86, 250].
Furthermore, threonine and the serines can be glycosylated, and the prolines can undergo cis-trans
isomerization.
The writers and erasers of the CTD phosphorylation marks are cyclin-dependent kinases and
phosphatases, respectively (Figure 2B) [92]. Whereas Pol II is unphosphorylated during PIC
assembly [134], it is then phosphorylated at S5 and S7 during initiation, primarily by the
Kin28 (human Cdk7) subunit of TFIIH [110]. Srb10 (human Cdk8) also contributes to basal
S5 phosphorylation. During elongation, S2 gets phosphorylated by Bur1 [182] and Ctk1 [28]
which enables eﬃcient RNA elongation and 3'-processing [3, 103]. Bur1 has also been shown to
be responsible for additional S7 phosphorylation during elongation [218]. Bur1 and Ctk1 share
homology with mammalian Cdk9, the kinase of the P-TEFb complex that triggers the transition
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Figure 2: RNA polymerase II C-terminal domain (CTD) structure and phosphorylation marks.
(A) Illustration of the relative length between the CTD in fully extended conformation and the core Pol II
adapted from [151]. Each black bar represents one of the 26 YSPTSPS heptad repeats of the S. cerevisiae
CTD. For size comparison, the structure of the CTD-interacting domain (CID) of termination factor Pcf11
is depicted in gold [150]. (B) The CTD can be phosphorylated at ﬁve of the seven repeat residues (Y1, S2,
T4, S5, S7). Respective kinases and phosphatases identiﬁed in S. cerevisiae are displayed above and below
the YSPTSPS heptad repeat, respectively. Kinases which act during initiation and elongation are depicted
using dashed and solid arrows, respectively. For CTD phosphorylation marks the same color-code is used
throughout this work.
into productive elongation [25, 140, 163]. For a long time it was believed that Cdk9 is the major
contributor to S2 phosphorylation in higher eukaryotes, but recent evidence suggests that the
ﬂy and human Cdk12 proteins also contribute to S2 phosphorylation, and that Bur1 and Ctk1
might be the orthologs of Cdk9 and Cdk12, respectively [7]. Dephosphorylation of the CTD by
speciﬁc phosphatases is less understood, but the current knowledge is that Fcp1 preferentially
dephosphorylates S2 [29, 113], while Rtr1 and Ssu72 are required for S5 dephosphorylation during
elongation and at termination, respectively [151, 156]. It has to be noted that the role of Rtr1 in
S5 dephosphorylation is rather controversial [240]. Moreover, it was recently shown that Ssu72 also
dephosphorylates S7 at the 3'-ends of genes [9]. Complete dephosphorylation of the Pol II CTD after
termination is also critical for Pol II recycling [29]. The yeast kinases and phosphatases required for
Y1/T4 phosphorylation and dephosphorylation remain to be identiﬁed.
The readers of this proposed CTD code are transcription and mRNA-processing factors with
binding preferences for diﬀerent phosphorylation patterns (Figure 3) [92]. During early transcription
S5 phosphorylation recruits the mRNA capping enzymes, early termination factor Nrd1, and the
Set1 histone methyltransferase [92, 114, 199, 224]. S2 phosphorylation occurs during transcription
elongation and functions, for example, in recruitment of chromatin modifying factors like Spt6 [213],
as well as RNA 3´-processing and termination factors Pcf11 and Rtt103 [3, 150]. Interaction between
the CTD and Spt6 is mediated by the C-terminal tandem SH2 domain of Spt6 [213], whereas
termination factors Nrd1, Pcf11, and Rtt103 contact the CTD via a conserved CTD-interacting
domain (CID) [150, 224]. Phosphorylations at S7 [22, 52, 110] and T4 [87] have roles in processing
of speciﬁc RNAs. Y1 phosphorylation was described for human Pol II almost two decades ago [8],
but whether this has a functional role and whether it exists in other species is unknown.
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Figure 3: Coordination of co-transcriptional pre-mRNA processing with the transcription cycle.
Figure adapted from [250]. The main phases of the transcription cycle and the coupled pre-mRNA
processing steps are indicated outside and inside the black arrows, respectively. For factors and Pol II CTD
phosphorylation marks that are further investigated in this work the same color-code is used throughout.
For details and references see text. Brieﬂy, non-phosphorylated Pol II assembles at the preinitiation
complex (PIC) together with Mediator and general transcription factors (GTFs). TFIIH associates last
and its associated kinase Kin28 phosphorylates Ser5 (shown in red) and Ser7 (not shown) on the CTD
enabling promoter clearance. Mediator-associated kinase Srb10 also contributes to basal levels of Ser5
phosphorylation. The Ser5P mark is important for recruitment of 5'-capping enzymes (CE), CTD-interacting
domain (CID)-containing termination factor Nrd1, and Set1 histone methyltransferase. Ser5P also contributes
to initial recruitment of the Bur1 kinase. Bur1 places promoter-proximal Ser2P marks (shown in blue),
which contributes to recruitment of the Ctk1 kinase. Ctk1 is the primary Ser2 kinase in yeast, and its
phosphorylation is required for eﬃcient transcription elongation and further pre-mRNA processing. Ser2P
recruits the Set2 histone methyltransferase and elongation factor Spt6. Moreover, Ser2P is required for
recruitment of the splicing machinery (SP), as well as subunits of the cleavage and polyadenylation (PA)
machinery. 3'-RNA processing and termination factors Pcf11 and Rtt103 both contain CIDs, which bind the
Ser2P CTD. The exonuclease complex (Exo) is also recruited through interaction between CTD and Rtt103
and through cooperative interaction between Rtt103 and Pcf11. Finally, complete dephosphorylation of the
Pol II CTD after termination is critical for Pol II recycling. Ser2P dephosphorylation is mediated by the
phosphatase Fcp1, whereas Ser5P dephosphorylation requires two phosphatases, Rtr1 and Ssu72.
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Figure 4: Structure and enzymatic synthesis of the m7G cap. Figure adapted from [204]. The cap consists
of 7-methylguanosine linked to the 5' nucleoside of the nascent RNA through an inverted 5'-5' triphosphate
bridge. The cap is formed by the sequential action of three enzymes (S. cerevisiae enzymes are given
in brackets). (A) RNA triphosphatase hydrolyses the γ-phosphate (green) of the 5´-triphosphate end of
the nascent RNA. (B) The truncated RNA 5´-end is then linked to an inverted guanylyl group by the
guanylyltransferase. First, a lysine side chain of the enzyme (E) reacts with the alpha phosphorus of GTP
(red) to form a covalent enzyme-guanylate intermediate (EpG). Second, the enzyme transfer of the GMP to
the 5' diphosphate RNA end forms a G cap and regenerates the apoenzyme. (C) RNA methyltransferase
transfers the methyl group from S-adenosylmethionine (AdoMet) to the G cap (red) to form a m7G cap and
releases S-adenosylhomocysteine (AdoHyc).
1.2.2 5'-capping
During initiation, the CTD of Pol II is phosphorylated at residue serine 5 (S5), which is important
for recruitment of RNA 5'-capping enzymes [114, 149, 199]. Capping starts with removal of the
terminal γ-phosphate from the 5´-triphosphate end of the nascent RNA, which is catalysed by the
RNA triphosphatase [35, 59, 203] (Figure 4). The truncated RNA 5´-end is then linked to an
inverted guanylyl group by the guanylyltransferase. Finally, the cap methyltransferase methylates
position N7 of the newly added terminal guanine. In S. cerevisiae the three catalytic activities are
encoded by Cet1, Ceg1 and Abd1. In metazoans the ﬁrst two steps of the capping reaction are
catalyzed by a single capping enzyme consisting of an N-terminal triphosphatase and a C-terminal
guanylyltransferase domain. The resulting 7-methyl-guanosine (m7G) cap protects the transcript
from degradation and promotes translation initiation of the mRNA [201, 208]. The complete cap
associates with the cap-binding complex (CBC) that functions in pre-mRNA splicing and mRNA
export [125, 202]. The CBC is a hetero-dimer consisiting of the cap-binding subunit CBP20 and
an auxiliary subunit CBP80 [21, 148], both of which are required for binding of the m7G cap
structure [239].
1.2.3 Splicing
During pre-mRNA splicing the coding segments of a gene (exons) are joined together, and the
interrupting, non-coding fragments (introns) are removed [235]. Splicing is mediated by the
spliceosome, a macromolecular ribonucleoprotein (RNP) complex comprised of ﬁve snRNPs and
numerous proteins. The spliceosome recognizes introns by short, conserved sequences in the nascent
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pre-mRNA (5´-splice site, branch point and 3´-splice site [20]) and helps to position reactive
groups of the nascent pre-mRNA for catalysis. Introns are then removed by two consecutive
transesteriﬁcation reactions [98]. Alternative splicing (e.g skipping of a particular exon) represents
a way to increase the complexity of transcriptomes and proteomes by producing several variable
mRNAs from a single pre-mRNA species. Alternative splicing is prevalent in higher eukaryotes and
is beyond the scope of this thesis (for a detailed review see [24]). Although S. cerevisiae contains
only few introns (∼95% of genes are intronless), almost one third of all mRNAs are produced from
the intron-containing genes  two thirds of which are highly expressed ribosomal protein genes
(RPGs) [162].
1.2.4 3'-end processing
The polyadenylation (pA) site in humans consists primarily of a highly conserved sequence element
with the consensus AAUAAA [179], whereas it is more degenerate in yeast. In S. cerevisiae it
is organized in an AU-rich eﬃciency element, an A-rich positioning element, and U-rich regions
surrounding the cleavage position and the site of poly(A) addition [155, 180]. When Pol II transcribes
past these signals, the transcript is processed by endonucleolytic cleavage and by subsequent addition
of a protective poly(A) sequence of about 70 nt (200 nt in humans).
The 3'-end RNA processing machinery consists of two multimeric complexes, CPF (cleavage and
polyadenylation factors) and CF (cleavage factor IA and B) [155]. Recruitment of these complexes
occurs via binding of subunits to the pA elements in the nascent transcript and/or the phosphorylated
CTD of Pol II (Section 1.2.1) [114, 150, 154]. Focused recruitment of RNA 3'-end processing factors
to the pA region via binding to the CTD of Pol II greatly enhances the cleavage and polyadenlytion
reactions [127].
A requirement of RNA 3'-end processing for eﬃcient transcription termination was already
established over 25 years ago [133]. Pcf11, an essential subunit of CF IA that interacts with nascent
RNA, also contains a CTD-interacting domain (CID) for binding the S2 phosphorylated CTD of
Pol II, promoting its recruitment to the 3'-end of genes [114, 150, 154]. Pcf11 has been shown to
possess an ability to dismantle elongation complexes in vitro [251, 252], dependent on its function in
RNA cleavage [111], thus playing a key role in coupling of transcription termination (Section 1.1.3)
to transcript cleavage and polyadenylation [13]. After cleavage and polyadenylation mature mRNAs
are exported to the cytoplasm for translation by the ribosomes.
1.3 Transcription regulation and RNA checkpoints
Regulation of gene expression is essential for normal cellular development and often occurs at the
level of transcription [55]. Although it was initially assumed that all regulation of transcription
takes place at the initiation stage via regulated recruitment of Pol II to gene promoters [168],
studies over the last decade have revealed that Pol II is subject to regulatory control at all stages
of the transcription cycle, especially during the initiation-elongation transition [1, 45].
In higher eukaryotes the transition from intitiation to elongation is often regulated by
promoter-proximal pausing (PPP) of Pol II [1, 243]. Although it was already observed in
the 1980s that transcription elongation could be a rate-limiting step in gene expression [192],
only recent advances in genome-wide studies (Section 2.2) enabled the identiﬁcation of PPP as
a widespread phenomenom in metazoans [34, 61, 158, 249]. To establish PPP, Pol II has ﬁrst to
be recruited to promoters, which depends on the intrinsic strength of the core promoter [99] and
on speciﬁc transcription factors that recruit chromatin-remodelling proteins and the transcription
machinery [71, 205]. Pol II then initiates transcription (Section 1.1.1) and starts to produce mRNA.
When the nascent RNA reaches 20-60 nt in length, DSIF (yeast Spt4-5) and NELF (negative
elongation factor) associate with the early elongation complex, inhibiting further synthesis.
P-TEFb can release Pol II from promoter-proximal pause sites by phosphorylating the CTD,
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DSIF and NELF, leading to dissociation of NELF and transformation of DSIF into a positive
elongation factor [244, 243]. P-TEFb recruitment, and thus pause release, can be triggered by
multiple mechanisms, including transcription factors, chromatin modiﬁcations, and co-regulatory
complexes [1]. This allows the duration of pausing to be diﬀerentially regulated from gene to gene.
While most of the key players controlling the initiation-elongation transition are conserved between
S. cerevisiae and higher eukaryotes, yeast and C. elegans apparently lack a NELF ortholog and
promoter-proximal pausing.
Despite regulation of gene expression via controlled recruitment of Pol II to gene promoters
or release of Pol II from promoter-proximal pause sites, co-transcriptional RNA processing also
presents a potential layer to modulate transcription [45, 168]. Like cell cycle checkpoints [238], RNA
checkpoints could ensure that the processing steps at each phase of the transcription cycle have
been accurately completed before progression into the next phase. Thus faulty transcripts, which
can lead to a large number of human diseases [32, 42], are degraded and only correctly processed
transcripts are exported for translation. Although a list of publications suggests the existence of
such RNA checkpoints (see below), the molecular mechanisms involved remain largely elusive.
The ﬁrst checkpoint may operate shortly after initiation at the level of 5' pre-mRNA capping.
Since promoter-proximal pausing co-occurs with capping of the nascent transcript and interactions
between the mammalian capping enzyme and DSIF have been reported [230], it has been proposed
that this pausing serves as a quality control checkpoint to ensure that only correctly capped
transcripts pursue the productive elongation phase of transcription [139, 168]. Although PPP has
not been observed in yeast under normal growth conditions so far, several lines of evidence suggest
that such a capping checkpoint could also exist in yeast. First, Spt5 interacts with the S. cerevisiae
and S. pombe capping enzymes [130, 173, 198], and second, the S. pombe P-TEFb homolog interacts
with the cap methyltransferase [68, 172]. Moreover, a quality control mechanism for mRNA 5'-end
capping was recently identiﬁed in S. cerevisiae [95], during which nascent RNAs without or with
aberrant cap structures are co-transcriptionally removed by the Rai1-Rat1 decay pathway.
During subsequent RNA processing steps control points may also operate. Splicing factors recruited
to nascent transcripts have been shown to stimulate productive elongation [54, 129]. Furthermore,
transcription termination depends on correct processing of RNA 3'-ends and defects in 3'-end
formation lead to accumulation of unprocessed transcripts near the sites of transcription [40, 80].
Hence, aberrant RNAs are not released and exported to the cytoplasm.
Finally, the recent discovery that most of the DNA of eukaryotic genomes is transcribed [89], giving
rise to a wealth of novel non-coding and potentially non-functional RNA species, further implies
a requirement for massive RNA quality surveillance in the nucleus. The future challenge will be
to unravel the underlying molecular mechanisms that are employed to distinguish functional from
non-functional RNAs and degrade the latter.
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2 Chromatin immunoprecipitation (ChIP)
Chromatin immunoprecipitation (ChIP) is a widely used method to measure the occupancy
level of proteins bound to DNA in vivo [5]. During the ChIP protocol, proteins are ﬁrst
cross-linked to DNA. In early ChIP studies, UV light was used for irreversible cross-linking of
proteins to DNA [62]. Nowadays the most used cross-linking agent is formaldehyde, which forms
heat-reversible protein-DNA and protein-protein cross-links. Thus, not only direct protein-DNA
contacts are observed, but also indirect protein-DNA interactions mediated by bridging proteins.
After cell lysis, the cross-linked chromatin is sheared into 100  800 bp fragments, either by
sonication or restriction enzyme digestion. It has been shown that extensive fragmentation,
leading to smaller fragment sizes between 75 and 300 bp, improves enrichment of protein binding
sites as well as resolution [53]. Sheared DNA fragments that are bound by the protein of
interest (or are bound by a protein carrying a speciﬁc protein modiﬁcation of interest) are then
selectively enriched via immunoprecipitation (IP) with protein/modiﬁcation-speciﬁc antibodies.
Alternatively, epitope-tagged proteins can be immunoprecipitated using tag-speciﬁc antibodies.
Typical control samples include input chromatin (sheared chromatin before IP), as well as mock IPs
using non-speciﬁc antibodies or untagged controls (see Section 2.1.2). The immunoprecipitated
protein-DNA complexes are then washed, cross-links reversed by heat, and proteins removed by
proteinase K digestion. Finally, the originally bound DNA fragments are identiﬁed either via
quantitative real-time PCR (qPCR) ampliﬁcation of a region of interest or via genome-wide detection
approaches (see below).
The ChIP method was ﬁrst described by Gilmour and Lis almost 30 years ago [62, 63]. During the
years 2000  2002, the ﬁrst genome-wide ChIP approaches were published [88, 122, 186]. Since then,
ChIP coupled to microarray hybridization (ChIP-chip, Section 2.1) has emerged as the standard
method for obtaining global DNA binding proﬁles of proteins. Furthermore, many bioinformatics
tools have been developed for the analysis of ChIP-chip data (Section 2.1.2). Over the past few
years, rapid advances in high-throughput sequencing technologies have facilitated ChIP coupled
to massively parallel sequencing (ChIP-seq, Section 2.2) to be commonly used as an alternative
to ChIP-chip. In accordance with that, many complementary genome-wide methods have been
established, some of which are also discussed in Section 2.2.
2.1 ChIP-chip
ChIP-chip essentially consists of ChIP (see above) followed by microarray (chip) hybridization,
allowing global detection of protein-DNA interactions. The capability of performing genome-wide
ChIP-chip studies of transcription factors as well as chromatin states and modiﬁcations, has greatly
aided our understanding of global gene regulation. Major breakthroughs include the dissection
of transcription regulatory networks [72, 122], genome-wide mapping of nucleosomes [123, 246]
and histone modiﬁcations [67, 78, 177], and the identiﬁcation of widespread post-initiation gene
regulation mechanisms [158, 249]. The ChIP-chip method consists of two parts (Figure 5),
an experimental wet lab part (Section 2.1.1) including ChIP, DNA ampliﬁcation, and array
hybridization, and a bioinformatics dry lab data analysis part (Section 2.1.2).
2.1.1 Experimental procedure
Since a single ChIP experiment often does not provide enough DNA suitable for microarray
hybridization, immunoprecipitated DNA fragments have to be ampliﬁed either by whole genome
ampliﬁciation (WGA) or ligation-mediated PCR (LM-PCR), two methods that have been shown to
introduce no (or only minimal) ampliﬁcation bias [96, 165]. After ampliﬁcation the DNA is labeled,
for instance by incorporation of a biotinylated nucleotide analog, and eventually loaded onto the
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Figure 5: ChIP-Chip is a powerful technique for genome-wide detection of in vivo protein-DNA interactions.
This method combines chromatin immunoprecipitation (ChIP) with DNA tiling microarray analysis (chip).
The ﬁgure illustrates the ChIP-chip protocol for S. cerevisiae cells containing a TAP-tagged version of
the protein of interest (POI). Brieﬂy, cells are grown to mid-exponential phase, followed by formaldehyde
cross-linking of proteins to other proteins and DNA. After cell lysis the chromatin is sheared by sonication, and
DNA fragments crosslinked to the POI are enriched by immunoprecipitation (IP) with IgG beads directed
against the TAP tag. The IP eﬃciency as well as the fold-enrichment over unoccupied genomic regions
is controlled by quantitative PCR (qPCR). Since the amount of DNA is usually too low for subsequent
genome-wide detection approaches such as ChIP-chip or ChIP-seq, IPed DNA fragments have to be ampliﬁed.
In case of ChIP-chip, ampliﬁed DNA is fragmented, labeled and eventually hybridized to an Aﬀymetrix
S. cerevisiae high-resolution tiling array. After hybridization the array is washed, stained and scanned. The
scanned array image provides intensity data for each probe indicating a relative level of hybridization with
the labeled target. Downstream bioinformatics analysis starts with data preprocessing and normalization.
Biological interpretation of the results involves inspection of the normalized ChIP enrichments in a genome
browser, followed by further analyses tailored to answer speciﬁc biological questions. These analyses include
gene-averaging of occupancy proﬁles, gene and/or assay clustering, and motif discovery.
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microarray. Labeling, hybridization, washing, and array scanning are performed using standard
protocols and kits provided by the manufacturer of the array platform used.
The major diﬀerences between state-of-the-art microarray platforms are single-color (Aﬀymetrix,
Santa Clara, CA; Illumina, San Diego, CA) versus two-color (Agilent Technologies, Palo Alto, CA;
NimbleGen Systems1, Madison, WI) systems. In the case of single-color arrays the IP and reference
(either input or mock IP) samples are hybridized on diﬀerent arrays, whereas the two-color system
allows the IP and reference samples to be labeled with diﬀerent dyes and to be hybridized on the
same array. Both systems provide comparable quality of results [96]. Whole-genome tiling arrays
represent the most robust array design since the entire genome, including the non-coding regions are
present. Tiling arrays consist of millions of short (25 to 60 nucleotides long) probes that cover the
genome at a constant spacing (4 to 100s of nucleotides). Compact genomes of model organisms like
yeast can be covered on a single microarray, whereas larger genomes need several microarrays for full
coverage. A state-of-the-art S. cerevisiae tiling microarray from Aﬀymetrix contains ∼3.2 million
25-mer oligonucleotide probes, covering the entire yeast genome at 4 bp resolution [44].
2.1.2 Bioinformatics data analysis
The scanned array images provide intensity data for each probe indicating a relative level of
hybridization with the labeled target. Since the genomic location of each probe is known,
construction of a genome-wide map of in vivo protein-DNA interactions is possible. The resolution
of the resulting ChIP-chip data depends mainly on two factors. First, the lengths of the sheared
DNA fragments enriched by the IP, and second the spacing and coverage of the probes on the
microarray.
Preprocessing of ChIP-chip data starts with quality controls of the raw data, followed by
intra-array and inter-array normalization (for a detailed protocol see online2 and Methods 5.7.1). In
any ChIP-chip experiment, it is important to correct for sequence- and genomic region-speciﬁc biases
in the eﬃciency of the various biochemical and biophysical steps of the protocol. Cross-linking,
chromatin fragmentation, IP, ampliﬁcation, labeling, and hybridization to the array all produce
biases that must be corrected for. Although reference-free normalization procedures have been
suggested that can reduce these biases [97], the cleanest and most eﬃcient method is to measure a
reference sample and to divide the true signals obtained from the IP by the reference intensities.
In our experience, this is the most important step in data normalization when using single-color
arrays with short probes such as the Aﬀymetrix arrays used here. These arrays exhibit a strong
probe sequence bias, meaning that the GC-content of a probe inﬂuences its measured intensity.
Usually input chromatin (i.e. sheared chromatin before IP) is used as reference. Mock IP (i.e.
using an unrelated antibody for which there is no corresponding epitope) represents a further
control experiment. The best kind of mock IP, which also allows to control for non-speciﬁc
antibody binding, is to use a strain that lacks the IP epitope, thus preventing speciﬁc binding of
the antibody used. In experiments using an epitope-tagged factor, this is easily achieved by using
the wild-type strain lacking the tag. Whereas published ChIP-chip studies usually use either input
DNA [200] or mock IP [225] as reference control, we decided to incorporate both controls for our
data normalization model which should correct for all sources of bias (see Methods 5.7.1).
It is advisable to measure at least two biological replicates for each factor or condition, as this
allows corrupted measurements to be easily identiﬁed. Furthermore, using N replicates reduces the
standard deviation of unsystematic noise by a factor of
√
N .
1NimbleGen was taken over by Roche in 2007. In June 2012 Roche exited the DNA microarray business.
2http://www.epigenesys.eu/images/stories/protocols/pdf/20111025112610_p47.pdf
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After quality control and proper normalization of the data, normalized probe intensity ratios or
occupancies can be viewed in open source genome browsers, e.g. IGV, IGB, or UCSC genome
browser, given that the data is in a suitable format, e.g. Gene Feature Format (GFF), or Browser
Extensible Data (BED). Further in-depth analysis largely depends on the factors/modiﬁcations
which are analysed and the biological questions that one wants to address.
Binding regions of site-speciﬁc transcription factors (TFs) are identiﬁed using peak detection
algorithms [97, 253], followed by motif discovery [73]. Many software packages for ChIP-chip
analysis have been published, which are tailored to the analysis of site-speciﬁc TFs [11, 93, 97].
Data normalization and peak detection using these methods rely heavily on the assumption that
most of the array probes are not bound by the factor of interest and can be used for modeling
non-speciﬁc hybridization background.
Since most of the yeast genome is transcribed by Pol II [44, 159], a large percentage of array
probes represent binding targets for Pol II and diﬀerent normalization and analysis techniques
are needed (see below and Methods 5.7.1). The same holds true for other frequent binders like
factors widely associated with Pol II, or certain histone modiﬁcations. ChIP-chip data of such
frequent binders can be represented by plotting gene-averaged metagene proﬁles covering entire
genes or speciﬁc gene regions (e.g. around the transcription start or polyadenylation sites), allowing
the occupancy distributions between gene groups to be compared. Gene groups can be either
predeﬁned, depending on ChIP enrichment, expression level, gene ontology, etc., or groups of genes
with similar occupancy identiﬁed using clustering methods [48]. When comparing experiments (e.g.
time courses) clustering can also be performed on the assay level. Features used for comparing gene
groups or clustering of genes, include peak levels or the shapes of the binding proﬁles of the genes.
Again, these features can be extracted for entire genes or speciﬁc gene regions. Of course all these
analysis methods can be applied not only to genes but also to other transcripts or any predeﬁned
targets. Finally, so far unannotated, novel targets that are bound be the protein of interest can be
identﬁed as well.
Preprocessing and analysis of ChIP-chip data can be carried out within the R environment
for statistical data analysis [183], using packages from the Bioconductor project [58]. Bioconductor
packages are available for data normalization as well as peak calling [219], and provide additional
functions, often speciﬁcally designed for a particular microarray platform (one-color [248] vs.
two-color [220]) or a particular sample type (e.g. site-speciﬁc TFs [50]). Additional user-deﬁned
methods for downstream analysis can be easily implemented in R.
2.2 ChIP-seq and other novel genome-wide approaches
Recently, ChIP-seq has emerged as a complementary or alternative to ChIP-chip for mapping global
protein-DNA interactions [171]. The ChIP part of the protocol is similar, but instead of labeling and
microarray hybridization, the immunoprecipitated material is used to construct a library of DNA
fragments which are ampliﬁed and then sequenced in parallel. Since the high-throughput sequencing
technology was still in its infancy and expensive when this work was initiated, we decided to use the
ChIP-chip method as the underlying technique for our studies. Recent comparison of ChIP-chip and
ChIP-seq data revealed that both methodologies produce comparable results and generate highly
reproducible proﬁles within each platform [84]. Overall ChIP-seq shows a better signal-to-noise
ratio and higher spatial resolution (i.e. narrower peaks). While this might to some extend aﬀect
the precision of peak identiﬁcation of site-speciﬁc TFs, ChIP proﬁles of frequent binders like Pol II
are very similar when microarray and sequencing data are compared [60]. Furthermore, it has to
be noted that general principles for ChIP-seq data normalization and the use of suitable control
(input) measurements are still not as mature as those implemented for ChIP-chip [84]. As the costs
for high-throughput sequencing will further decrease, and general normalization principles are being
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established, ChIP-seq will become the method of choice in future research.
Advances in high-throughput sequencing technology gave rise to many novel genome-wide approaches
over the past years. In 2012, Frank Pugh's lab published a new method that further improves the
resolution of ChIP-seq by applying lambda exonuclease to chromatin immunoprecipitates to digest
DNA that is not directly contacted by the protein of interest. This allows mapping of transcription
factor binding sites at single nucleotide resolution [188]. Moreover, genome-wide densities of Pol II
can also be obtained using global run-on sequencing (GRO-seq, [34, 43, 196]) or native elongating
transcript sequencing (NET-seq, [30]). Whereas ChIP is not strand-speciﬁc and cannot determine
whether Pol II complexes are active, GRO-seq and NET-seq allow identiﬁcation of transcriptionally
engaged Pol II in a strand-speciﬁc manner. Compared to ChIP and GRO-seq, NET-seq provides
nucleotide resolution but is so far only established for S. cerevisiae.
In addition to genomic proﬁling of the transcription machinery and transcription associated
chromatin states, gene expression analysis and more recently transcriptomics represent prominent
complementary assays that are essential for studying global gene regulation. Whereas traditional
transcriptomics methods (using gene-expression/tiling microarrays [44] or RNA-sequencing [159])
allow only to obtain steady state transcript levels, the recently developed dynamic trancriptome
analysis (DTA) allows to measure mRNA synthesis and decay rates, without perturbation of the
cellular system, providing higher sensitivity and temporal resolution [153, 214].
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3 Aims and scope of this thesis
Transcription of protein-coding genes is a multi-step process in which Pol II synthesizes a mature
mRNA in concert with various transcription initiation, elongation, termination, chromatin modifying
and RNA processing factors (Section 1). Since the synthesis of mRNA depends on the interaction
of proteins with DNA, it is essential to investigate genome-wide occupancy proﬁles of the various
factors involved in transcription, to better understand global gene regulation.
The aim of this thesis was to perform high-resolution genome-wide occupancy proﬁling by chromatin
immunoprecipitation (ChIP, Section 2) of Pol II, its phosphorylated CTD isoforms (Section 1.2.1),
as well as components of the initiation (Section 1.1.1), elongation (Section 1.1.2), termination (Sec-
tion 1.1.3), and RNA processing machinery (Section 1.2) in proliferating S. cerevisiae cells.
ChIP was coupled to Aﬀymetrix tiling microarrays that cover the entire yeast genome at 4 bp
resolution [44] (ChIP-chip, Section 2.1). For data normalization (Section 2.1.2), we developed a
novel procedure that corrects for non-speciﬁc antibody binding by using input reference as well as
mock immunoprecipitation control measurements (Methods 5.7.1). Since previous ChIP publications
focused only on a small subset of factors [225] and/or investigated only single genes [108, 176] and/or
were obtained using microarrays with low resolution [177], we aimed at generating a comprehensive
genome-wide binding map covering all phases of the transcription cycle at great detail.
Open questions in the ﬁeld were whether all Pol II associated transcription factors assemble at all
genes or if subsets of genes recruit distinct sets of proteins according to the gene-speciﬁc needs
of the transcribing Pol II complex. Moreover, although it was known that the Pol II complex
undergoes changes in factor composition during the course of transcription [108, 176], the precise
changes in factor composition as well as the exact genomic locations of such transitions were poorly
characterized. The mechanistic details underlying these transitions were also hardly understood.
Furthermore, no genome-wide studies have examined whether factor recruitment correlates with
speciﬁc Pol II CTD phosphorylations.
By establishing and performing ChIP-chip occupancy proﬁling in S. cerevisiae cells in combination
with statistical data analysis and further biochemical and biophysical assays, we were able to obtain
answers to all these questions. Statistical analysis of the genome-wide occupancy levels of the Pol II
transcription machinery presented in this work point to a general Pol II transcription complex 
that is, one composed of all factors  that mediates transcription and mRNA processing at all
actively transcribed Pol II genes in yeast. At both ends of genes this complex undergoes uniform
transitions in factor composition that are independent of gene length, gene type or expression
level (Section 6). Changes in the Pol II transcription complex occur as a function of the distance
from the transcription start site and polyadenylation site, respectively. Moreover, our results
indicate that mRNA 5´ cap completion underlies the initiation-elongation transition and triggers
productive Pol II elongation (Section 7) and that Pol II CTD tyrosine 1 dephosphorylation underlies
the elongation-termination transition and triggers mRNA 3´ processing and termination (Section 8).
Parts of this work were performed in cooperation with Andreas Mayer, Matthias Siebert,
and Amelie Schreieck (see page 9 and the individual Results Sections for detailed contributions).
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Part II
Materials and Methods
4 Materials
4.1 Bacterial and yeast strains
Strain Description Source
XL-1 Blue Rec1A; endA1; gyrA96; thi-1; hsdR17; supE44; relA1;
lac[F' proAB lacIqZΔM15Tn10(Tetr)]
Stratagene
Table 2: E. coli strain used in this work
Strain Description Source
wild-type BY4741; MATa; his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems
Bur1-TAP BY4741; BUR1::TAP::HIS3MX6 Open Biosystems
Cet1-TAP BY4741; CET1::TAP::HIS3MX6 Open Biosystems
Ctk1-TAP BY4741; CTK1::TAP::HIS3MX6 Open Biosystems
Elf1-TAP BY4741; ELF1::TAP::HIS3MX6 Open Biosystems
Kin28-TAP BY4741; KIN28::TAP::HIS3MX6 Open Biosystems
Paf1-TAP BY4741; PAF1::TAP::HIS3MX6 Open Biosystems
Pcf11-TAP BY4741; PCF11::TAP::HIS3MX6 Open Biosystems
Rpb3-TAP BY4741; RPB3::TAP::HIS3MX6 Open Biosystems
Spn1-TAP BY4741; SPN1::TAP::HIS3MX6 Open Biosystems
Spn1-TAP Elf1-3HA BY4741; SPN1::TAP::HIS3MX6; ELF1::3HA::KANMX6 A. Mayer
Spt4-TAP BY4741; SPT4::TAP::HIS3MX6 Open Biosystems
Spt5-TAP BY4741; SPT5::TAP::HIS3MX6 Open Biosystems
Spt6-TAP BY4741; SPT6::TAP::HIS3MX6 Open Biosystems
Spt6∆C-TAP FY119; Matα; his4-912 lys2-128 leu2-1 ura3-52 trp1-63 S. Dengl
Spt16-TAP BY4741; SPT16::TAP::HIS3MX6 Open Biosystems
TFIIB-TAP BY4741; SUA7::TAP::HIS3MX6 Open Biosystems
Tfg1-TAP BY4741; TFG1::TAP::HIS3MX6 Open Biosystems
Table 3: S. cerevisiae strains used in Section 6
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Strain Description Source
wild-type BY4741; MATa; his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems
Cet1-TAP BY4741; CET1::TAP::HIS3MX6 Open Biosystems
Ceg1-TAP RS453; MATa; CEG1::TAP::TRP1-KL K. Sträßer
Abd1-TAP BY4741; ABD1::TAP::HIS3MX6 This work
Cet1-TAP Spt5∆CTR BY4741; CET1::TAP::HIS3MX6; SPT5Δ931-1063::KANMX6 This work
Ceg1-TAP Spt5∆CTR RS453; CEG1::TAP::HIS3MX6; SPT5Δ931-1063::KANMX6 This work
Abd1-TAP Spt5∆CTR BY4741; ABD1::TAP::HIS3MX6; SPT5Δ931-1063::KANMX6 This work
bur2∆ BY4741; bur2::KANMX6 Open Biosystems
bur2∆ Cet1-TAP BY4741; bur2::KANMX6; CET1::TAP::HIS3MX6 This work
bur2∆ Abd1-TAP BY4741; bur2::KANMX6; ABD1::TAP::HIS3MX6 This work
CBP20-TAP BY4741; CBP20::TAP::HIS3MX6 Open Biosystems
CBP80-TAP BY4741; CBP80::TAP::HIS3MX6 Open Biosystems
cbp20∆ BY4741; cbp20::KANMX6 Invitrogen
cbp20∆ Bur1-TAP BY4741; cbp20::KANMX6; BUR1::TAP::HIS3MX6 This work
cbp20∆ Ctk1-TAP BY4741; cbp20::KANMX6; CTK1::TAP::HIS3MX6 This work
cbp20∆ Elf1-TAP BY4741; cbp20::KANMX6; ELF1::TAP::HIS3MX6 This work
cbp20∆ Spn1-TAP BY4741; cbp20::KANMX6; SPN1::TAP::HIS3MX6 This work
cbp20∆ Spt4-TAP BY4741; cbp20::KANMX6; SPT4::TAP::HIS3MX6 This work
cbp20∆ Spt5-TAP BY4741; cbp20::KANMX6; SPT5::TAP::HIS3MX6 This work
cbp20∆ Spt6-TAP BY4741; cbp20::KANMX6; SPT6::TAP::HIS3MX6 This work
cbp20∆ Spt16-TAP BY4741; cbp20::KANMX6; SPT16::TAP::HIS3MX6 This work
Anchor-away wild-type
(AA)
HHY168; MATα; ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15
ura3 GAL psi+ tor1-1 fpr1::NAT RPL13A-2xFKBP12::TRP1
Euroscarf
AA Bur1-TAP HHY168; BUR1::TAP::HIS3MX6 This work
AA Ctk1-TAP HHY168; CTK1::TAP::HIS3MX6 This work
AA Abd1-FRB HHY168; ABD1::FRB::KANMX6 This work
AA Abd1-FRB-GFP HHY168; ABD1::FRB::GFP::KANMX6 This work
AA Abd1-FRB Bur1-TAP HHY168; ABD1::FRB::KANMX6; BUR1::TAP::HIS3MX6 This work
AA Abd1-FRB Ctk1-TAP HHY168; ABD1::FRB::KANMX6; CTK1::TAP::HIS3MX6 This work
AA Abd1-FRB
CBP20-TAP
HHY168; ABD1::FRB::KANMX6; CBP20::TAP::HIS3MX6 This work
Table 4: S. cerevisiae strains used in Section 7
Strain Description Source
Nrd1-TAP BY4741; NRD1::TAP::HIS3MX6 Open Biosystems
Rna14-TAP BY4741; RNA14::TAP::HIS3MX6 Open Biosystems
Rna15-TAP BY4741; RNA15::TAP::HIS3MX6 Open Biosystems
Rtt103-TAP BY4741; RTT103::TAP::HIS3MX6 Open Biosystems
AA Glc7-FRB HHY168; GLC7::FRB::KANMX6 A. Schreieck
Table 5: S. cerevisiae strains used in Section 8
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4.2 Primers and plasmids
All DNA primers were synthesized by Thermo Fisher Scientiﬁc GmbH Ulm, Germany.
Name Sequence (5' → 3')
ADH1 5' Fw TCCTTGTTTCTTTTTCTGCAC
ADH1 5' Rv GAGATAGTTGATTGTATGCTTGG
ADH1 ORF Fw AGCCGCTCACATTCCTCAAG
ADH1 ORF Rv ACGGTGATACCAGCACACAAGA
ADH1 3' Fw AAAACGAAAATTCTTATTCTTGA
ADH1 3' Rv TACCTGAGAAAGCAACCTGA
ACT1 5' Fw AAACCAAACTCGCCTCTCT
ACT1 5' Rv GGAAGGAAAGGATCAAACAA
ACT1 ORF Fw TCAGAGCCCCAGAAGCTTTG
ACT1 ORF Rv TTGGTCAATACCGGCAGATTC
ACT1 3' Fw TTTATCCATTGGACCGTGTA
ACT1 3' Rv GGGCAATTGCATAAACCTAT
ILV5 5' Fw ACCCAGTATTTTCCCTTTCC
ILV5 5' Rv TTGTCTATATGTTTTTGTCTTGC
ILV5 ORF Fw CTATCAAGCCATTGTTGACC
ILV5 ORF Rv CTTGAAGACTGGGGAGAAAC
PMA1 5' Fw TGACTGATACATCATCCTCTT
PMA1 5' Rv TTGGCTGATGAGCTGAAACAGAA
PMA1 ORF Fw AAATCTTGGGTGTTATGCCATGT
PMA1 ORF Rv CCAAGTGTCTAGCTTCGCTAACAG
PMA1 3' Fw GGTTTCTCTGGATGGTACTTT
PMA1 3' Rv TGACTTGTGTGCGTTTCATA
YER (Control) Fw TGCGTACAAAAAGTGTCAAGAGATT
YER (Control) Rv ATGCGCAAGAAGGTGCCTAT
Table 6: qPCR primers used in this work
Name Sequence (5' → 3')
Abd1 FRB(-GFP) Fw ATTCCGTAAGGTAAAACAGTATATCGAACCGGAAAGCGTAAAGCCCAAC
cggatccccgggttaattaa
Abd1 FRB(-GFP) Rv ACGGCCGAAATACAGATGCTTTATAGTAGGGTTATTGTTTCTATTCATTTTTATT
gaattcgagctcgtttaaac
Spt54CTR Fw AGCTGTAAATGCGCATGGAGGCTCAGGTGGTGGCGGTGTC
taacggatccccgggttaattaag
Spt54CTR Rv TTGATTTCTTCTTGGGTGATATTGGTTCTCCTTTTGGTGA
cgcataggccactagtggatc
Table 7: Primers used for C-terminal FRB(-GFP) tag integration and for deletion of the 15 C-terminal
hexapeptide repeats (CTR, amino acids 931 to 1063) of Spt5.
Sequence parts which are homologous to the protein of interest and the FRB(-GFP) tag (plasmids pFA6a-
FRB-KanMX6 and pFA6a-FRB-GFP-KanMX6; Table 9) or the KanMX6 casette (plasmid pFA6a-3HA-
KanMX6; Table 9) are in capital and lower case letters, respectively.
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Name Sequence (5' → 3')
Abd1 TAP Fw CATTCCGTAAGGTAAAACAGTATATCGAACCGGAAAGCGTAAAGCCCAAC
cgtacgctgcaggtcgac
Abd1 TAP Rv CGAAATACAGATGCTTTATAGTAGGGTTATTGTTTCTATTCATTTTTATT
atcgatgaattcgagctcg
Bur1 TAP Fw GATGAGTCTAAGGAGTTCCAAAATAGTGATATTGCAGATCTATAT
cgtacgctgcaggtcgac
Bur1 TAP Rv GTAATTAGCCACGAGGCCAGAAAGGAAGAGAGAATAGTATAACCT
atcgatgaattcgagctcg
CBP20 TAP Fw GACCAGGTTTCGATGAAGAAAGAGAAGATGATAACTACGTACCTCAG
cgtacgctgcaggtcgac
CBP20 TAP Rv TATATATCTGTGTGTAGAATCTTTCTCAGATATAAATTGATTGATTCT
atcgatgaattcgagctcg
Cet1 TAP Fw GTTATCGTCTTTATCATATGAAATTTTTGAAGGTTCAAAGAAAGTCATG
cgtacgctgcaggtcgac
Cet1 TAP Rv TCTCGCTCAAGGGCATTTGCTTATTTTTTTTTGAAATGATTCAAATA
atcgatgaattcgagctcg
Ctk1 TAP Fw GTAATAGTAATAATAATAATAATAATAATAATGACGATGATGATAAA
cgtacgctgcaggtcgac
Ctk1 TAP Rv TAATCTATTTTTTGTGTCTACTTATTTCAATTGGCTATATATCCTT
atcgatgaattcgagctcg
Elf1 TAP Fw GCCAAGTTAAAAGAGGCAGAGGCGCCTTGGTAGATAGTGACGATGAA
cgtacgctgcaggtcgac
Elf1 TAP Rv ATATAAAATATATATGACCTAAGTAAATATGGTTTTTTCTCAGGACCGGA
atcgatgaattcgagctcg
Spn1 TAP Fw GTGAGATGTACAAGAGGTTGACTTCAAGATTAAACAAGAAGCATAAA
cgtacgctgcaggtcgac
Spn1 TAP Rv CATATGATACATATCTCAAAGCATTACGGAATTACCTGTTTTGTTATT
atcgatgaattcgagctcg
Spt4 TAP Fw CTGTTGCCTCACTACAAACCGAGGGATGGCAGTCAAGTTGAG
cgtacgctgcaggtcgac
Spt4 TAP Rv AATTCATTACTATTATACATGTGATATCAGAACGGAAGGTTT
atcgatgaattcgagctcg
Spt5 TAP Fw CAAGGAAATAAGTCAAACTATGGTGGTAACAGTACATGGGGAGGTCAT
cgtacgctgcaggtcgac
Spt5 TAP Rv CTTTTTTATTGATTTCTTCTTGGGTGATATTGGTTCTCCTTTTGGTGATT
atcgatgaattcgagctcg
Spt6 TAP Fw GACGCTTCTAAAATCTAACAGTAGTAAGAATAGAATGAACAACTACCGT
cgtacgctgcaggtcgac
Spt6 TAP Rv GGTCAAAGTAATAATAAAATTAATAATAACAATGGACACTACATACGCAT
atcgatgaattcgagctcg
Spt16 TAP Fw GAGAAAAAGGCTGCTAGGGCTGATAGGGGTGCAAACTTTAGAGAT
cgtacgctgcaggtcgac
Spt16 TAP Rv CAGATCAAGGTCTTGCTGGTGAAACCCAGTAAGTGTTATAAGTCTA
atcgatgaattcgagctcg
Table 8: Primers used for C-terminal TAP tag integration by homologous recombination. Sequence parts
which are homologous to the protein of interest and the TAP tag (plasmid LL280; Table 9) are in capital
and lower case letters, respectively.
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Name Description Source Application
LL280 T7; TAP tag; ColEI origin; Ampr L. Larivière TAP tagging
pFA6a-FRB-KanMX6 FRB::KanMX6; pBR322 origin; Ampr Euroscarf Anchor away
pFA6a-FRB-GFP-
KanMX6
FRB::GFP::KanMX6; pBR322 origin; Ampr Euroscarf Anchor away
pFA6a-3HA-KanMX6 3HA::KanMX6; pBR322 origin; Ampr H. Feldmann Spt5 CTR deletion
Table 9: Plasmids used in this work
4.3 Antibodies
Antibody Amount in ChIP Source
1Y26 (Rpb3) 5 μl (lyophilized ascites dissolved in 100 μl ddH2O) NeoClone Biotechnology
3D12 (Y1P) 50 μl (supernatant cell culture) Elisabeth Kremmer/Dirk Eick
3E8 (S5P) 20 μl (supernatant cell culture) Elisabeth Kremmer/Dirk Eick
3E10 (S2P) 25 μl (supernatant cell culture) Elisabeth Kremmer/Dirk Eick
4E12 (S7P) 50 μl (supernatant cell culture) Elisabeth Kremmer/Dirk Eick
BL2894 (S2P) 2 μl Bethyl Laboratories
Table 10: Antibodies used for ChIP. All antibodies but BL2894 are monoclonal.
Antibody Usage Host Source
α-Pgk1 1:10000 Mouse K. Sträßer
α-Tubulin 1:1000 Rat Santa Cruz (sc-69971)
PAP (Peroxidase-Anti-Peroxidase) 1:2000 Rabbit SIGMA (P1291)
α-Mouse-HRP 1:3000 Goat Bio-Rad (170-6516)
α-Rat-HRP 1:3000 Goat SIGMA (A9037)
Table 11: Antibodies used for western blotting
4.4 Media and supplements
Name Description Application
LB 1% (w/v) tryptone; 0,5% (w/v) yeast extract; 0,5% (w/v) NaCl;
(+ 1,5% (w/v) agar for solid media plates)
E. coli culture
YPD 2% (w/v) petone; 2% (w/v) glucose; 1,5% (w/v) yeast extract;
(+ 2% (w/v) agar for solid media plates)
S. cerevisiae culture
SC -his 0.69% (w/v) yeast nitrogen base; 0.077% (w/v) drop-out -his;
2% (w/v) glucose; (+ 2% (w/v) agar for solid media plates)
S. cerevisiae culture
Table 12: Growth media
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Additive Description Working concentration
Ampicillin Antibiotic 100 μg/ml
Geneticin (G418) Antibiotic 400 μg/ml
Rapamycin Immunosuppressive drug 1 μg/ml
Table 13: Growth media additives
4.5 Buﬀers and solutions
Name Description Application
1x TBE 8.9 mM Tris-HCl; 8.9 mM Boric acid; 2 mM EDTA;
pH 8.0 at 25°C
Agarose gels
TFB-1 Buﬀer 30 mM KOAc; 50 mM MnCl2; 100 mM RbCl; 10 mM CaCl2;
15% (v/v) Glycerol; pH 5.8 at 25°C
Chemically competent
E. coli cells
TFB-2 Buﬀer 10 mM MOPS, pH 7.0 at 25°C; 10 mM RbCl; 75 mM CaCl2;
15% (v/v) Glycerol
Chemically competent
E. coli cells
TELit 10 mM Tris-HCl, pH 8.0 at 25°C; 155 mM LiOAc;
1 mM EDTA, pH 8.0;
Chemically competent
S. cerevisiae cells
LitSorb 10 mM Tris-HCl, pH 8.0 at 25°C; 155 mM LiOAc;
1 mM EDTA, pH 8.0; 18.2% (w/v) D-Sorbitol
Chemically competent
S. cerevisiae cells
LitPEG 10 mM Tris-HCl, pH 8.0 at 25°C; 155 mM LiOAc;
1 mM EDTA, pH 8.0; 40% (w/v) PEG 3350
Chemically competent
S. cerevisiae cells
LiOAc/DTT 0.1 M LiOAc; 30 mM DTT Electroporation of
S. cerevisiae cells
Lyticase Buﬀer 1 M Sorbitol; 100 mM EDTA, pH 8.0;
14.3 mM β-Mercaptoethanol;
Preparation of
genomic DNA
Spheroblast wash
Buﬀer
1 M Sorbitol; 100 mM EDTA, pH 8.0 Preparation of
genomic DNA
TE 50/100 50 mM Tris-HCl, pH 7.5 at 4°C; 100 mM EDTA, pH 8.0 Preparation of
genomic DNA
Lysis Buﬀer 50 mM Tris-HCl, pH 7.5; 10 mM EDTA, pH 8.0,
1:500 β-Mercaptoethanol; 1:1000 Lyticase (10 U/ml)
Preparation of
genomic DNA
2x SDS loading
Buﬀer
25 mM Tris-HCl, pH 7.0 at 25°C; 0.05% (w/v) Bromophenol
blue; 0.5% (v/v) β-Mercaptoethanol; 7% (w/v) Dithiothreitol;
0.05% (w/v) Lauryl sulfate; 5% (v/v) Glycerol
SDS-PAGE
4x Stacking gel
Buﬀer
0.5 M Tris-HCl; 0.4% (w/v) SDS; pH 6.8 at 25°C SDS-PAGE
4x Separation gel
Buﬀer
3 M Tris-HCl; 0.4% (w/v) SDS; pH 8.9 at 25°C SDS-PAGE
SDS running Buﬀer 25 mM Tris-HCl; 0.1% (w/v) SDS; 250 mM Glycine SDS-PAGE
Gel stain 50% (v/v) Ethanol; 7% (v/v) Acetic acid;
0.125% (w/v) Coomassie Brilliant Blue R-250;
SDS-PAGE
Gel destain 5% (v/v) Ethanol; 7.5% (v/v) Acetic acid SDS-PAGE
1x PBS 2 mM KH2PO4; 4 mM Na2HPO4; 140 mM NaCl; 3 mM KCl;
pH 7.4 (25°C)
Western blotting
WB transfer Buﬀer 25 mM Tris; 192 mM Glycine; 20% (v/v) Ethanol Western blotting
WB blocking Buﬀer 2% (w/v) milk powder in 1x PBS Western blotting
Table 14: General buﬀers and solutions
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Name Description
1x TBS 20 mM Tris-HCl, pH 7.5 at 4°C; 150 mM NaCl
FA lysis Buﬀer 50 mM HEPES-KOH, pH 7.5 at 4°C; 150 mM NaCl; 1 mM EDTA;
1% (v/v) Triton X-100; 0.1% (v/v) Na deoxycholate; 0.1% (v/v) SDS; PI;
PhoI*
FA lysis Buﬀer 2 Identical to FA lysis Buﬀer, but with 500 mM NaCl instead of 150 mM NaCl
ChIP wash Buﬀer 10 mM Tris-HCl, pH 8.0 at 4°C; 0.25 M LiCl; 1 mM EDTA;
0.5% (v/v) NP-40; 0.5% (v/v) Na deoxycholate
TE Buﬀer 10 mM Tris-HCl, pH 7.4 at 4°C; 1 mM EDTA
ChIP elution Buﬀer 50 mM Tris-HCl, pH 7.5 at 25°C; 10 mM EDTA; 1% (v/v) SDS
RNase storage Buﬀer 10 mM HEPES, pH 7.5 at 25°C; 20 mM NaCl; 0.1% (v/v) Triton X-100;
1 mM EDTA; 50% (v/v) Glycerol
Protease-inhibitor mix (PI) 1 mM Leupetin; 2 mM Pepstatin A; 100 mM Phenylmethylsulfonyl ﬂuoride;
280 mM Benzamidine
Phosphatase-inhibitor mix (PhoI) 1 mM NaN3; 1 mM NaF; 0.4 mM Na3VO4
Table 15: Buﬀers and inhibitor mixes used for ChIP.
* The phosphatase inhibitor mix (PhoI) was only used for ChIP experiments of Pol II phopho-isoforms.
All standard buﬀers and solutions were prepared according to Sambrook & Russell, 2001.
5 Methods
5.1 Molecular Cloning
5.1.1 Polymerase Chain Reaction (PCR)
A standard PCR reaction such as for the validation of TAP-tagged yeast strains was performed as
follows. PCR reactions contained 3 μl (∼150 ng) genomic DNA template (Section 5.2.3), 1.25 μl
of 10 μM forward and reverse primer (usual length 18 to 22 nt), 5 μl 10x Taq Buﬀer, 6 μl of
10 mM MgCl2, 2.5 μl of 2 mM dNTP-Mix, 30 μl H2O and 1 μl Taq DNA Polymerase. PCR was
performed on a T3000 Thermocycler (Biometra) using a 2 min denaturing step at 94°C, followed by
35 cycles of 30 sec at 94°C, 30 sec at 50°C and 1 min/kb at 72°C. Finally, the PCR reaction was
incubated at 72°C for 10 min and stored at 4°C.
PCR products ampliﬁed from plasmids (Table 9) used to generate new yeast strains by homologous
recombination (Section 5.2.1) were typically generated as follows. PCR reactions contained 1 μl
(∼100 ng) plasmid DNA template, 2 μl of 10 μM forward and reverse primer (∼50 nt long,
Tables 7 and 8), 10 μl 5x HF Buﬀer, 5 μl of 2 mM dNTP-Mix, 29 μl H2O and 1 μl Phusion DNA
Polymerase. PCR was performed on a T3000 Thermocycler (Biometra) using a 30 sec denaturing
step at 98°C, followed by 35 cycles of 7 sec at 98°C, 20 sec at 55°C and 25 sec/kb at 72°C. Finally,
the PCR reaction was incubated at 72°C for 10 min and stored at 4°C.
In cases where no or only low yield of PCR product was obtained, the standard protocols were
adjusted by changing the PCR parameters, including the type of DNA polymerase, primer annealing
temperature and elongation time.
5.1.2 Agarose gel electrophoresis
Electrophoretic separation of DNA was performed in horizontal 1x TBE agarose gels that contained
SYBR Safe (0.01 μg/ml; Invitrogen). Depending on the size of the DNA molecules that were
separated, the agarose concentration was varied between 0.8% and 2% (w/v). Agarose gel
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electrophoresis was carried out in PerfectBlue Gelsystem electrophoresis devices from Peqlab (110 V,
35 min). DNA samples were mixed with 6x loading dye (Fermentas). The sizes of the separated DNA
molecules were assessed with the help of the GeneRulerTM 1kb DNA ladder or the GeneRulerTM
100bp DNA ladder (Fermentas).
5.1.3 Transformation of E. coli cells and preparation of plasmid DNA
For transformation of E. coli cells chemically competent XL-1 Blue cells (see Table 2) were
used. Approximately 2 μg of DNA were added to 50 μl of competent cells and incubated for 5 min
on ice. Next, cells were heated for 30 sec at 42°C in a water bath and then put back on ice for 2 min.
Transformed E. coli cells were recovered by incubation at 37°C for 1 h in 700 μl of LB medium.
Recovered cells were centrifuged at 13,000 rpm for 30 sec (at room temperature) and 650 μl of the
supernatant was removed. Cells were resuspended in the remaining volume and plated onto solid
LB medium plates containing the respective antibiotic (see Table 13). Plates were incubated at
37°C overnight.
Chemically competent E. coli cells were prepared as follows. 200 ml LB medium (containing the
respective antibiotic) were inoculated with 5 ml of an overnight culture of the desired E. coli strain.
Cells were grown at 37°C (160 rpm) to an OD600 of 0.4 to 0.5 and incubated on ice for 10 min. The
following steps were performed at 4°C with pre-cooled buﬀers (see Table 14). Cells were harvested
by centrifugation and washed with 50 ml TFB-1 Buﬀer. After a second centrifugation step, cells
were resuspended in 4 ml TFB-2 Buﬀer. Aliquots of competent E. coli cells were frozen in liquid
nitrogen and stored at -80°C.
For preparation of plasmid DNA, 5 ml LB medium (containing the respective antibiotic)
were inoculated with a single colony and incubated at 37°C overnight (160 rpm). Cells were
harvested by centrifugation at 4,500 rpm for 10 min (4°C). Next, plasmid DNA was prepared with
the QIAquick Miniprep Kit (Qiagen) according to the manufacturer's instructions.
5.2 Yeast methods
5.2.1 Generation of S. cerevisiae strains and epitope tagging
All S. cerevisiae strains used in this work are listed in Tables 3 to 5. TAP-tagged yeast strains were
either obtained from Open Biosystems (Huntsville, USA; Yeast TAP-Tagged Collection) or generated
by integration of the TAP tag (ampliﬁed from the LL280 plasmid) into the genome, C-terminal of
the respective genes, by homologous recombination. Deletion of the 15 C-terminal hexapeptide
repeats (CTR, amino acids 931 to 1063) of Spt5 was done by homologous recombination with the
KanMX6 cassette, ampliﬁed from the pFA6a-3HA-KanMX6 vector. For nuclear depletion of Abd1
using the anchor-away method [76] a FKBP12-rapamycin-binding (FRB) tag was introduced at the
C-terminus of Abd1. Anchor-away strains were generated as described [76] using PCR products
ampliﬁed from plasmids pFA6a-FRB-KanMX6 and pFA6a-FRB-GFP-KanMX6 (P30578/P30580,
Euroscarf). All plasmids used are listed in Table 9.
The bur24 and cbp204 deletion strains were obtained from Open Biosystems and Invitrogen,
respectively.
5.2.2 Transformation of S. cerevisiae cells
For transformation of chemically competent S. cerevisiae cells 10 μl of DNA
(≥ 1 μg of linear DNA) and 360 μl LitPEG (Table 14) was added to 50 μl of competent
cells. After incubation at room temperature for 30 min, 47 μl DMSO was added and in case that
the yeast strain was not temperature-sensitive heated at 42°C for 15 min. Alternatively, if the yeast
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strain was temperature-sensitive cells were incubated at 30°C for 10 min and at 37°C for 5 min.
After recovery (30°C, 1 h, 150 rpm), cells were collected by centrifugation at 2,000 rpm for 3 min
(room temperature) and the supernatant was removed. Transformed yeast cells were resuspended
in 50 μl sterile ddH2O, plated on selective media plates and incubated at 30°C for 2-5 days.
Chemically competent S. cerevisiae cells were prepared as follows. 50 ml YPD medium was
inoculated (start OD600 of 0.2) with yeast that was grown to stationary phase over-night. Next,
yeast cells were grown at 30°C (150 rpm) to an OD600 of 0.5 to 0.7 and harvested by centrifugation
at 4,000 rpm for 10 min (room temperature). Yeast cells were washed with 25 ml sterile ddH2O
and ﬁnally resuspended in 360 μl LitSorb. 40 μl of heated (10 min at 100°C) salmon sperm DNA
was added. Aliquots of competent yeast cells were stored at -80°C.
For transformation by electroporation 100 ml YPD medium was inoculated (start
OD600 of 0.15) with yeast that was grown to stationary phase overnight (cells of 100 ml
culture were enough for one transformation). Next, yeast cells were grown at 30°C (150 rpm) to
an OD600 of 0.7 to 0.8 and harvested by centrifugation at 4,000 rpm for 5 min (4°C). Afterwards
the cells were washed two times with 50 mL ice-cold sterile ddH2O and one time with 50 mL
ice-cold 1 M sorbitol (5 min, 4,000 rpm, 4°C). Next the cell pellet was resuspended in 20 mL
0.1 M LiOAc/30 mM DTT and incubated for 30 min at 150 rpm and 30°C. The cells were harvested
and the pellet was washed two times with 50 mL ice-cold 1 M sorbitol and ﬁnally resuspended in
1 ml 1 M sorbitol. After transfer to an Eppendorf reaction tube and centrifugation for 1 min at
4,000 rpm (4°C) the pellet was resuspended in 100 μl ice-cold 1 M sorbitol. For transformation 5 μl
of DNA (≥ 1 μg of linear DNA) was added to 100 μl of cell suspension. The mixture was transferred
to an electroporation cuvette which was put into a MicroPulserTM Electroporator (Bio-Rad) and
a pulse of 2.5 kV (5 ms) was applied (program Sc2). Then 1 ml of pre-warmed YPD medium was
added to the cells and the suspension transferred to an Eppendorf reaction tube. If needed, the
transformed S. cerevisiae cells were recovered by incubation at 30°C and 350 rpm for 2 h. Finally,
the cells were plated on selective plates (for TAP tag insertion Histidin, Table 12) and incubated
at 30°C for 2-5 days.
5.2.3 Preparation of genomic DNA
For preparation of genomic DNA 5 ml yeast were grown at 30°C (150 rpm) overnight. Cells were
harvested by centrifugation at 2,500 rpm for 5 min (4°C), washed with 1 ml sterile ddH2O and
resuspended in 500 μl Lyticase Buﬀer. Next, 20 μl Lyticase (10 U/μl) were added. After incubation at
37°C for 45 min, yeast spheroblasts were collected by centrifugation at 5,000 rpm for 5 min (4°C). The
supernatant was removed and spheroblasts were gently resuspended in 1 ml Spheroblast wash Buﬀer.
Spheroblasts were centrifuged again and resuspended in 500 μl Spheroblast wash Buﬀer. Spheroblasts
were collected again and resupended in 500 μl of TE 50/100 Buﬀer. 50 μl 10% SDS were added
and incubated at 70°C for 30 min. Then, 250 μl 5 M Potassium acetate were added and incubated
on ice for 15 min. The precipitated genomic DNA was collected by centrifugation at 13,000 rpm
for 20 min (4°C), the supernatant was removed and 700 μl Isopropanol was added. Precipitated
genomic DNA was collected by centrifugation at 13,000 rpm for 10 min (4°C). Precipitated DNA
was washed with 70% Ethanol and resuspended in 500 μl TE 50/100 Buﬀer via heating at 42°C
for 30 min. DNA quantity and quality control was performed with a ND-1000 Spectrophotometer
(NanoDrop Technologies). Genomic DNA was stored at -20°C.
Alternatively, yeast genomic DNA was prepared using the QIAcube robotic workstation (Qiagen).
From the overnight culture a volume corresponding to OD600 of 5.0 was centrifuged for 5 min
at 3,000 rpm and resuspended in 180 μl Lysis Buﬀer. The QIAcube was run according to the
manufacturer's instructions using the protocol DNeasy Blood & Tissue - Bacteria (Gram+) or
yeast  Enzymatic lysis. The yield of DNA was within the range of 50-100 ng/μl.
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5.3 Protein methods
5.3.1 Preparation of whole cell extracts for western analysis
For preparation of whole cell extracts, yeast cultures were grown overnight in YPD and transferred
into 100 ml of YPD to adjust the starting OD600 to 0.15. Cells were grown at 30°C to mid-log phase
(OD600 ∼0.8). Subsequent steps were performed at 4°C with pre-cooled FA lysis Buﬀer containing
protease inhibitors (Table 15). Cells were collected by centrifugation (5 min at 4,000 rpm), and
washed with 20 ml FA lysis Buﬀer. Cell pellets were resuspended in 1 ml FA lysis Buﬀer, and
disrupted by bead beating (Retsch) in the presence of 1 ml silica-zirconia beads for 30 min at 4°C.
The beads were removed and the lysates clariﬁed by centrifugation at top speed for 30 min at 4°C.
Protein concentration was determined using the Bio-Rad Protein Assay (Bio-Rad), and ∼40 μg of
total protein was applied to SDS-PAGE (5.3.2) followed by western analysis (Section 5.3.3).
5.3.2 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE)
Electrophoretic separation of protein samples was performed by SDS-PAGE with 15% acrylamide
gels (acrylamide:bisacrylamide ratio = 37.5:1) [119] in Bio-Rad gel systems. Before loading onto
the gel, protein samples were mixed with SDS-PAGE loading Buﬀer and boiled at 95°C for 5 min.
Protein samples requiring broader or higher resolution separation, were separated by ready-to-use
NuPAGE Novex Bis-Tris minigels (Invitrogen) according to the manufacturer's instructions. MES
and MOPS running buﬀers (Invitrogen) were used. Gels were stained with Gel staining solution at
room temperature for at least 20 min and destained at room temperature overnight in Gel destaining
solution. Corresponding buﬀers and solutions are listed in Table 14.
5.3.3 Western blotting
For western blotting the protein sample was separated by SDS-PAGE as described in Section 5.3.2.
Separated proteins were then transferred to a PVDF membrane (Schleicher & Schuell; pre-
equilibrated with 100% Ethanol) in the presence of the WB transfer Buﬀer (see Table 14). Thereby,
the wet blotting system from Bio-Rad was used according to the manufacturer's instructions.
Transfer was performed at 100 V for 1 h at 4°C. After transfer, the membrane was blocked for at least
30 min with WB blocking Buﬀer. The blot was then incubated for 1 h (room temperature) with the
primary antibody in WB blocking Buﬀer. The blot was washed three times with 1x PBS for 10 min
and then incubated with the secondary antibody in WB blocking Buﬀer for 1 h (room temperature).
Afterwards, the blot was washed three times with 1x PBS for 10 min. Secondary antibodies were
usually coupled to horseradish peroxidase. Final signals were detected with the Chemiluminescence
Kit (Pierce) followed by exposure of the blot to high-sensitivity ﬁlms (Invitrogen). Films were
developed with the X-omat M35 developing machine (Kodak).
5.4 Microscopy
To conﬁrm nuclear depletion of Abd1 using the anchor-away method [76], we tagged the Abd1-FRB
fusion protein with GFP (strain AA Abd1-FRB-GFP, Table 4, Section 5.2.1) and monitored GFP
ﬂuorescence upon rapamycin treatment. S. cerevisiae cells were grown in YPD with 40 mg/l adenine
hemisulfate at 30°C to an OD600 of ∼0.6. Cultures were split and incubated with equal volumes of
either rapamycin (1 µg/ml f.c. in DMSO) or DMSO at 30°C for another 60 min. Cells were resolved
in water and inspected under the microscope (Leica DM2500, EL 6000). Camera DFC365FX and
Software LAS AF 6000 Modular Systems Version 2.6.0.7266 (Leica) were used for image analysis.
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5.5 Chromatin immunoprecipitation followed by quantitative real-time PCR
(ChIP-qPCR)
5.5.1 ChIP using TAP-tagged proteins
TAP-tagged yeast strains were usually obtained from Open Biosystems (Huntsville, USA; Yeast
TAP-Tagged Collection) and were isogenic to BY4741 wild-type strain. All TAP-tagged strains
used in this work are listed in Tables 3 to 5. Before these yeast strains were applied to ChIP
analysis, the strains were validated. First, gene-speciﬁc PCR was performed to conﬁrm that the
DNA coding for the TAP-tag was at the correct genomic position (Section 5.1.1). Second, western
blotting with anti-TAP antibody (PAP, Table 11) was performed to verify whether the tagged
protein of interest was properly expressed. Western blot experiments were conducted as described
in Section 5.3.3. Third, the growth of the various tagged yeast strains compared to non-tagged
wild-type strain was monitored to rule out any inﬂuence of the epitope tag on yeast growth. This
was done by serial dilutions of the various yeast strains on YPD plates at 30°C for two days. Only
yeast strains which passed all quality controls were used for ChIP analysis.
For standard ChIP-qPCR experiments yeast cultures were grown in 40 ml YPD medium at
30°C to mid-log phase (OD600 ∼0.8), treated with 1% formaldehyde (Sigma) for 20 min at 20°C,
and cross-linking was quenched with 5 ml 3 M glycine for 10 min. For Abd1 anchor-away ChIP
experiments yeast cultures were grown in 80 ml YPD to an OD600 ∼0.6, split and incubated
with equal volumes of either rapamycin (1µg/ml f.c. in DMSO) or DMSO at 30°C for another
60 min before formaldehyde cross-linking. Subsequent steps were performed at 4°C with pre-cooled
buﬀers containing protease inhibitors (PI; Table 15). Cells were collected by centrifugation,
washed twice with 1x TBS and twice with FA lysis Buﬀer. Cell pellets were ﬂash-frozen in liquid
nitrogen and stored at -80°C. Pellets were thawed, resuspended in 1 ml FA lysis Buﬀer, and
disrupted by bead beating (Retsch) in the presence of 1 ml silica-zirconia beads (Roth) for 30 min
at 4°C. Lysis eﬃciency was typically >80% as determined by spectrophotometer measurements
(BioPhotometer, Eppendorf). Chromatin was solubilized and fragmented via sonication with a
BioruptorTM UCD-200 (Diagenode Inc.). Sonication was performed at intensity setting high
(cycles of 0.5 min on and 0.5 min oﬀ) for 35 min with sample cooling on ice after 5, 15 and 25 min.
30 μl and 100 μl of fragmented chromatin samples were saved as input and for control of the average
chromatin fragment size (described in Section 5.5.3), respectively. 700 μl of sample (IP sample)
was immunoprecipitated with 20 μl IgG Sepharose 6 Fast Flow beads (GE Healthcare) at 4°C
for 1 h. The IgG beads were directed against the Protein A content of the C-terminal TAP tag.
Immunoprecipitated chromatin was washed three times with FA lysis Buﬀer, twice with FA lysis
Buﬀer 2, twice with ChIP wash Buﬀer and once with TE Buﬀer. Immunoprecipitated chromatin
was eluted for 10 min at 65°C with ChIP elution Buﬀer. Eluted chromatin was digested with
Proteinase K (20 µl of 20 mg/ml Proteinase K from Engyodontium album, Sigma) at 37°C for 2 h
and the reversal of crosslinks was performed at 65°C overnight. DNA was puriﬁed with the QIAquick
PCR Puriﬁcation Kit (Qiagen) according to the manufacturer's instructions. Thereby, DNA was
eluted with 50 μl ddH2O and was further analyzed by quantitative real-time PCR (Section 5.5.4).
All buﬀers and reagents used for ChIP are listed in Table 15.
5.5.2 ChIP using antibodies against Pol II
ChIP analysis of the various Pol II phospho-isoforms was performed as described in the previous
section, but with the following modiﬁcations. First, ChIP experiments were conducted in the
presence of phosphatase inhibitors (PhoI; Table 15). Second, for chromatin immunoprecipitation
a set of monoclonal antibodies with strong speciﬁcity and aﬃnity for particular phosphorylated
states of the Pol II CTD were applied (Table 10). These antibodies were generated and validated in
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the laboratories of Dirk Eick and Elisabeth Kremmer (Helmholtz ZentrumMünchen). The amount of
antibody that was used for immunoprecipitation of chromatin was optimized as is described in [146].
700 μl of chromatin sample was immunoprecipitated with the optimized amount of the respective
antibody (see Table 10) at 4°C overnight on a rotating wheel. 25 μl of Protein A and Protein G
Sepharose beads (GE Healthcare) were added and incubated at 4°C for 1.5 h on a rotating wheel.
Immunoprecipitated chromatin was treated as described in the previous section.
5.5.3 Control of average chromatin fragment size
100 μl of chromatin solution was used to determine the average DNA fragment size that was reached
by sonication. 92 μl of TE Buﬀer and 8 μl of Proteinase K (20 mg/ml) was added to the chromatin
sample and incubated at 37°C for 2 h and at 65°C overnight. Next, 20 μl of LiCl (4 M), 1 μl
Glycogen and 120 μl Phenol was added, mixed and centrifuged at 13,000 rpm for 10 min (20°C).
The supernatant was mixed with 400 μl of pre-cooled Ethanol and incubated at -20°C for 5 h. The
immunoprecipitated DNA (and RNA) was pelletized by centrifugation at 13,000 rpm for 20 min
(4°C). The pellet was resuspended in 20 μl TE Buﬀer and RNA was removed by RNase treatment.
10 μl of RNase A/T1 mix (2 mg/ml RNase A, 5000 U/ml RNase T1, Fermentas) were added and
incubated at 37°C for 1 h. The resulting DNA sample was electrophoretically separated on a 1.5%
agarose gel (see Section 5.1.2). The average DNA fragment size was ∼250 bp.
5.5.4 Quantitative real-time PCR (qPCR)
For ChIP experiments, input and immunoprecipitated (IP) samples were assayed by qPCR to assess
the extent of protein occupancy at diﬀerent genomic regions.
Before ChIP DNA was analyzed by qPCR, primers were designed and the PCR eﬃciencies of the
corresponding primer pairs were determined. DNA primers used for qPCR experiments were 18 to
24 nt long and were designed with the OligoPerfectTM Designer (Invitrogen). The length of the
ampliﬁed qPCR product was between 60 and 70 nt. The PCR eﬃciency was determined by qPCR
(as described below) with the same primer pair applied to at least four diﬀerent dilutions of a DNA
template (usually DNA that was fragmented by sonication). Based on the resulting standard curve,
the PCR eﬃciency was calculated with the Bio-Rad CFX Manager software version 1.1 according
to the manufacturer's instructions. Only primer pairs with a PCR eﬃciency of ≥ 90% were used in
ChIP-qPCR experiments. A list of all qPCR primers used in this work is given in Table 6.
PCR reactions for the analysis of ChIP DNA as well as for validation of qPCR primer pairs contained
1 μl DNA template, 2 μl of 10 μM primer pairs and 12.5 μl iTaq SYBR Green Supermix (Bio-Rad).
Quantitative PCR was performed on a Bio-Rad CFX96 Real-Time System (Bio-Rad) using a 3 min
denaturing step at 95°C, followed by 49 cycles of 30 sec at 95°C, 30 sec at 61°C and 15 sec at 72°C.
Threshold cycle (Ct) values were determined by application of the corresponding Bio-Rad CFX
Manager software version 1.1 using the Ct determination mode Regression. The IP eﬃciency and
fold enrichment of any given region over control regions, such as an open reading frame (ORF)-free
heterochromatic region on chromosome V, was determined as described [53].
5.6 Chromatin immunoprecipitation followed by tiling microarray analysis
(ChIP-chip)
5.6.1 ChIP for ChIP-chip
For ChIP-chip experiments the standard ChIP protocol as described in Sections 5.5.1 to 5.5.3 had
to be adapted as follows. First, yeast cultures were grown in 600 ml YPD medium at 30°C to
mid-log phase (OD600 ∼0.8). Second, cell lysis via bead beating was performed for 2 h, with
cooling of the sample after 30, 60 and 90 min. Third, the chromatin pellet was washed two times
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with FA lysis Buﬀer before sonication. Washing was performed as follows. The cell lysate was
centrifuged at 13,200 rpm for 15 min (4°C), the supernatant was discarded and the chromatin pellet
was resuspened with 1 ml FA lysis Buﬀer. Fourth, the elution from the IgG Sepharose beads was
performed at 65°C for 60 min. Fifth, after puriﬁcation of DNA with the QIAquick PCR Puriﬁcation
Kit (Qiagen), DNA was eluted with 100 μl H2O and 5 μl RNase A (10 mg/ml, Sigma) was added,
and incubated at 37°C for 20 min. DNA was puriﬁed with the QIAquick PCR Puriﬁcation Kit,
eluted with 50 μl H2O, concentrated via vacuum centrifugation, and ampliﬁed as described in the
following section.
5.6.2 DNA ampliﬁcation
DNA samples were ampliﬁed and re-ampliﬁed with GenomePlex© Complete Whole Genome
Ampliﬁcation 2 (WGA2) Kit using the Farnham Lab WGA Protocol for ChIP-chip3 [165]. Brieﬂy,
10 μl of concentrated ChIP DNA was used to generate the PCR-ampliﬁable OmniPlex© Library,
consisting of ChIP DNA molecules ﬂanked by universal priming sites. Library preparation was
performed essentially as described in the technical bulletin of the WGA2 Kit (Sigma). The
OmniPlex© Library was then ampliﬁed by PCR within a limited number of cycles. This ﬁrst
whole genome ampliﬁcation step was conducted according to the manufacturer's instructions.
The ampliﬁed DNA was puriﬁed with the QIAquick PCR Puriﬁcation Kit (Qiagen). DNA was
eluted with 50 μl H2O and the DNA quantity and quality control was performed with a ND-1000
Spectrophotometer (NanoDrop Technologies), and was usually larger than 1 μg. In addition, DNA
quality was monitored by agarose gel electrophoresis. 15 ng of puriﬁed DNA was re-ampliﬁed
as described in the technical bulletin of the WGA2 Kit, but with the following modiﬁcation.
Re-ampliﬁcation was carried out in the presence of 0.4 mM dUTP. Incorporation of dUTP was
a prerequisite for the enzymatic fragmentation of DNA (described in the following section). After
ampliﬁcation DNA was puriﬁed with the QIAquick PCR Puriﬁcation Kit. DNA was eluted with 50
μl H2O and the DNA quantity and quality control was assessed with a ND-1000 Spectrophotometer,
and agarose gel electrophoresis.
5.6.3 DNA fragmentation, labeling and microarray processing
The enzymatic fragmentation, labeling, hybridization and array scanning were done according
to the manufacturer's instructions4. Enzymatic fragmentation and terminal labeling were
performed by application of the GeneChip WT Double-Stranded DNA Terminal Labeling
Kit (P/N 900812, Aﬀymetrix). Brieﬂy, re-ampliﬁed DNA was fragmented in the presence of 1.5 μl
Uracil-DNA-glycosylase (10 U/μl) and 2.25 μl APE1 (100 U/μl) at 30°C for 1 h 15 min. The average
fragment size was in the range of 50-70 bp as determined by automated gel electrophoresis on an
Experion system (Bio-Rad) that allows the analysis of small amounts of DNA. The fragmented DNA
was then labeled at the 3´-end by adding 2 μl and 1 μl of Terminal nucleotidyl transferase (TdT,
30 U/μl) and GeneChip DNA Labeling Reagent (5 mM), respectively.
5.5 μg of fragmented and labeled DNA were hybridized to a high-density custom-made Aﬀymetrix
tiling array [44] (PN 520055) at 45°C for 16 h with constant rotational mixing at 60 rpm in a
GeneChip Hybridization Oven 640 (Aﬀymetrix). Washing and staining of the tiling arrays were
performed using the FS450_0001 script of the Aﬀymetrix GeneChip Fluidics Station 450. The
arrays were scanned using an Aﬀymetrix GeneChip Scanner 3000 7G. The resulting raw data image
ﬁles (.DAT) were inspected for any impairment.
3http://www.genomecenter.ucdavis.edu/farnham/protocol.html
4Aﬀymetrix Chromatin Immunoprecipitation Assay Protocol P/N 702238
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5.7 ChIP-chip data analysis
The data generated by one ChIP-chip experiment consists of an intensity value for each DNA
probe. These values measure the relative quantity of DNA at the probe's genomic position in
the immunoprecipitated or input (reference) material. The ﬂuorescence intensity for each probe
is determined from the scanned array image, and when using the Aﬀymetrix platform saved in a
binary .CEL ﬁle. The .CEL ﬁles together with a mapping (.bpmap) ﬁle, which maps each probe to
its genomic position along the reference genome, are the input ﬁles for further data processing and
analysis.
5.7.1 Data preprocessing and normalization
The ﬁrst steps in data preprocessing comprise the quality control of the obtained data as well as
normalizations to render the data comparable between diﬀerent arrays, to correct for saturation
eﬀects, and to obtain enrichment and occupancy values.
All data normalization procedures performed in this work were done using R [183] and
Bioconductor [58]. For data import of the Aﬀymetrix .CEL ﬁles and the conversion into the
basic Bioconductor object class for microarray data ExpressionSet, we used the R package
Starr [248]. Quality assessment of each measured array was done by inspection of raw image
ﬁles, density-plots, scatter-plots, and MA-plots, in order to avoid processing of ﬂawed arrays (for
a detailed protocol see online5). Subsequent data normalization consisted of three steps. First,
we performed quantile normalization between replicate measurements (not between non-replicate
measurements). Second, for each condition (including the reference measurements) we averaged the
signal for each probe by calculating the geometric average over the replicate intensities. Third, data
obtained using TAP-tagged factors was normalized using a combined mock IP plus input reference
normalization, whereas data obtained using speciﬁc antibodies (e.g. Pol II phospho-isoforms [Y1P,
S2P, T4P, S5P, S7P]) was normalized simply by dividing through input reference intensities. The
rationale for the last step is explained in detail below.
In ChIP-chip experiments, it is important to correct for sequence- and genomic region-speciﬁc
biases in the eﬃciency of the various biochemical and biophysical steps. Cross-linking, chromatin
fragmentation, IP, ampliﬁcation, labeling, and hybridization to the array can produce biases.
Although reference-free normalization procedures have been suggested that can reduce these
biases [97], the cleanest and most eﬃcient method is to measure a reference signal and to divide the
true signal obtained from the IP by the reference intensities, allowing accurate ratio measurements
to be obtained. This is in our experience the most important step in data normalization when using
single-color arrays with short probes such as the Aﬀymetrix arrays used here. These arrays exhibit
a strong probe sequence bias, meaning that the GC-content of a probe inﬂuences its measured
intensity.
As reference signal one can use the intensities obtained by hybridizing the input (sheared chromatin
before IP) fraction to a tiling array or, alternatively, a mock IP (using an unrelated antibody for
which there is no corresponding epitope). Here, we developed a simple mathematical model to
describe the fragmentation, ampliﬁcation, labeling, and hybridization biases, as well as the bias
through unspeciﬁc antibody binding, in order to understand the eﬀects of diﬀerent normalization
procedures. We found that, using either the mock IP or the matched input as reference signal, one
can only correct for some of these eﬀects. Based on our model, we derive a combined normalization
using both mock IP and input signal which should correct for all these sources of bias. Crucial
to our method is that our mock IP employs the same antibody as the factor IP, but using an
isogenic wild-type yeast strain lacking the IP epitope. In experiments using epitope-tagged factors,
5http://www.epigenesys.eu/images/stories/protocols/pdf/20111025112610_p47.pdf
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as the TAP-tagged factors investigated here, this is easily achieved by using the corresponding
wild-type strain lacking the tag. This way, we measure unspeciﬁc binding of the TAP tag-directed
antibody that can be used for subtracting the unspeciﬁc binding component in the factor IP. Since
for ChIP-chip of the Pol II phospho-isoforms no mock IP measurements with the same antibody as
used for the IP could be done, only input reference normalization was performed.
Combined mock IP and input reference normalization: Let x be the genomic coordinate,
B(x), M(x), and S(x) the array signals obtained from hybridizing the input, the mock IP, and the
factor IP, respectively, and p(x) the occupancy proﬁle due to the speciﬁc binding of the antibody to
the factor of interest. We can model these array signals by
B(x) = aBÖb(x),
M(x) = aMÖb(x)Öu(x),
S(x) = aSÖb(x)Ö(u(x) + p(x)),
with aB, aM , and aS unknown scaling constants for the input, mock IP, and factor IP
array measurements, respectively, b(x) the input intensity proﬁle describing the fragmentation,
ampliﬁcation, labeling, and hybridization biases, and u(x) the proﬁle describing the eﬀect of
unspeciﬁc binding of the antibody to other DNA-bound proteins and protein complexes. We seek
to obtain the occupancy proﬁle p(x). Using normalization with the input, we would get
S(x)/B(x) = (aS/aB)Ö(p(x) + u(x)),
showing that the unspeciﬁc binding of the antibody will lead to distortions of the ChIP enrichment
signal which will be the more serious the less speciﬁc the antibody binds to the factor and the less
sequence speciﬁcity the factor has in binding to the genomic DNA. Using normalization with the
mock IP, we would obtain
S(x)/M(x) = (aS/aM)Ö(1 + p(x)/u(x)),
which should work better than the previous version in cases where unspeciﬁc binding dominates the
signal from the speciﬁc binding, but which introduces a bias through sequence-speciﬁc eﬀects of the
unspeciﬁc binding (e.g. through a nucleosome density-mediated GC bias of the unspeciﬁc binding
signal).
We therefore introduce a combined normalization using both the input and mock IP signals:
(S(x)− (aS/aM)ÖM(x))/B(x) = (aS/aB)Öp(x).
If we assume that X% of the genomic regions do not bind the factor of interest, we can estimate the
factor aS/aM as the global (X/2)% quantile of S(x)/M(x),
aS/aM = Q(X/2)%[S(x)/M(x)]
since with this choice (X/2)% of the values of the normalized signal (S(x)−(aS/aM)×M(x))/B(x)
will be below zero. Note that, in practice, the value of aS/aM depends only weakly on the value of
X and can be estimated to much better than a factor 2. Only when severely overestimating it (by
more than a factor of 2) the correction of unspeciﬁc binding will be detrimental.
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To be able to give absolute occupancy values on a scale between 0% and 100%, we need to estimate
the factor aS/aB. For this purpose, we assumed that the highest occupancies of our measured
factors correspond to 100% occupancy. We estimate the highest genome-wide occupancies using
the Y% quantile instead of the genome-wide maximum probe signal to obtain an estimation that is
robust against statistical noise. In this study, we chose a quantile of Y = 99.8% for all factors, which
corresponds to the highest-bound ∼6000 probes on our tiling arrays. Then, aS/aB is estimated as
the Y% quantile of the factor occupancy:
aS/aB = QY%[(S(x)− (aS/aM)ÖM(x))/B(x)]
Our normalization method should improve on the normalization procedures commonly used by
correcting the signal for unspeciﬁc antibody binding. Our method cannot correct for sequence
dependent eﬀects of cross-linking eﬃciency. These eﬀects represent, however, an inherent limitation
of ChIP-chip and ChIP-seq techniques.
We used the combined mock IP plus input normalization method to calculate occupancy
proﬁles for all TAP-tagged factors. ChIP-chip data obtained using speciﬁc antibodies (e.g. Pol II
phospho-isoforms [Y1P, S2P, T4P, S5P, S7P]) was normalized simply by dividing through genomic
input intensities, since for these no mock IP measurements with the same antibody as used for the
IP could be done.
Replicate measurements, reference samples, and data quality control: At least two
independent biological replicates were analyzed for each factor (Pearson correlations between
replicates were usually R > 0.8). Using N replicates reduces the standard deviation of unsystematic
noise by a factor of
√
N . It is important that correlation calculations between replicates
are performed after reference normalization. Mock IP and input measurements were used for
normalization (see above). Two biological replicates were used for the mock IP (R = 0.65). Due to
the very high reproducibility/correlation between input samples of diﬀerent factors (comparable to
factor replicate correlations, R > 0.8), we took input samples of three factors, Rpb3, Spt4, and Spt6,
and used them as triplicate measurements to normalize all factors investigated in Section 6 except
the Pol II phospho-isoforms and Spt6∆C. The latter and all factors investigated in Sections 7 and 8
were normalized using their matched input data.
5.7.2 Calculation of transcript-wise occupancy proﬁles
In order to calculate occupancy proﬁles over genes or other genomic features the normalized
occupancy signal at each nucleotide of the region was calculated as the median signal of all probes
overlapping this position (6.5 probes on average). Individual probe intensities were further smoothed
using the sliding window smoothing procedure (window half size of 75 bp) implemented in the R
package Ringo [220].
5.7.3 Transcript-averaging of occupancy proﬁles
For metagene analysis we averaged the normalized ChIP-chip proﬁles over representative sets of
preﬁltered genes: We start with all nuclear S. cerevisiae S288C protein-coding genes classiﬁed as
'veriﬁed' or 'uncharacterized' by the Saccharomyces Genome Database (SGD, 5769 genes). To
align gene proﬁles across entire transcripts, only genes with available TSS and pA assignments
from RNA-seq experiments [159] were taken into account (4366 genes). Genes with TSS (pA)
measurements downstream (upstream) of the annotated ATG (Stop) codon were excluded. To
remove possible wrongly annotated TSSs and pAs, we only included genes with TSS (pA)
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annotations showing a distance of less than 200 bp to the corresponding downstream (upstream)
ATG (Stop) codon (3448 genes). As a result of the limited ChIP-chip resolution and the
compactness of the yeast genome with its short intergenic regions (median inter-ORF length:
368 bp, median inter-transcript length: 259 bp), a gene's factor occupancy proﬁle can have
spurious contributions from ﬂanking genes. To minimize these spill-over eﬀects, we focused
on genes exhibiting a minimal ORF and transcript distance to ﬂanking genes of 250 bp and
200 bp, respectively (1786 genes). Furthermore, we restricted our analysis to the 50% highest
expressed nuclear protein-coding genes according to [46] (1140 genes, ALL set). We grouped
genes into four ORF length classes: Xtremely Short (XS) ranging from 256 to 511 bp, Short (S)
512 to 937 bp, Medium (M) 938 to 1537 bp, and Long (L) 1538 to 2895 bp, comprising 93, 266,
339, and 299 genes, respectively. Proﬁles within these or other (e.g. ribosomal protein genes)
selected gene classes were scaled to median gene length, and gene-averaged proﬁles calculated
by taking the median or the 5% trimmed mean at each genomic position over the ChIP-chip proﬁles.
To facilitate the comparison of elongation factor occupancies and in particular their slope in
the region near the TSS, we shifted the traces in Figure 6E and F (Section 6) by up to 0.1 on the
occupancy scale such that they overlapped in the region [TSS-250, TSS].
To avoid scaling of proﬁles within gene classes, ALL genes were cut around the TSS (for
Figure 17A: from 250 bp upstream to 650 bp downstream; only genes longer than 680 bp were
considered; 910 genes) or the pA site (for Figure 28: from 400 bp upstream to 400 bp downstream;
only genes longer than 800 bp and with more than 400 bp distance to neighboring genes were
considered; 619 genes) and averaged at each genomic position.
5.7.4 Calculation of factor proﬁle peaks and transitions
To calculate peak positions of averaged ChIP-chip proﬁles, median proﬁles were calculated in a
region ± 250 bp around the TSS or the pA site, and smoothed with cubic splines (R package: stats,
function: smooth.spline, parameter: spar = 0.9). The maximum value of the smoothed curve was
selected as peak position. To estimate the uncertainty of the peak position, we drew 1000 bootstrap
samples from the set of genes, recalculated peak positions for each bootstrap sample as described,
and estimated their scatter using the Median Absolute Deviation (MAD) measure.
We also used the gene-averaged ChIP-chip proﬁles to calculate transitions in the transcription
complex, i.e. genomic positions where factors associate with or dissociate from transcribing Pol II.
To determine 5´ transitions, median proﬁles were calculated in a region ± 150 bp around the
TSS, and smoothed with cubic splines. The position at 11.5% occupancy of the smoothed curve
(corresponding to the point after which the elongation factor proﬁles start to change) was deﬁned as
5´ transition point. 3´ transitions were determined as the percentage of the maximum occupancy
at 100 bp downstream of the pA site. Median proﬁles were calculated in a region from 250 bp
upstream of the TSS to 250 bp downstream of the pA site, and smoothed with cubic splines. The
uncertainty of the 5´ and 3´ transitions was determined as described above.
To calculate gene-wise peak distances between capping enzymes Cet1-Ceg1 and Abd1 (Section 7,
Figure 18B), ChIP-chip proﬁles were cut around the TSS (from 150 bp upstream to 350 bp
downstream) for each gene contained in the M gene length class (see Section 5.7.3), and smoothed
with cubic splines. The maximum value of the smoothed curve was selected as peak position, and
the distances calculated. Only genes with detectable peaks were selected.
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5.7.5 Calculation of pairwise proﬁle correlations and correlation network construction
Analyses were done using 4366 genes with available TSS and pA annotations [159]. Pairwise
Pearson correlations over factor occupancy proﬁles were calculated between concatenated gene
proﬁles, ranging each from TSS−250 bp to pA+250 bp, and provided as a similarity metric. The
correlation-based network was calculated using the GraphViz's Neato algorithm [56] employing an
edge-weighted, spring-embedded layout procedure attempting to minimize a global energy function,
which is equivalent to statistical multi-dimensional scaling.
5.7.6 Singular value decomposition (SVD)
For each factor (or Pol II phospho-isoform) f and for each of the 4366 genes g for which we
had TSS and pA annotations [159], we calculated 90%-quantiles of occupancies within a region
[TSS−250 bp, pA+250 bp] as a robust proxy for peak occupancies. This resulted in a f × g
matrix. From each matrix element, we subtracted the average over its row (i.e. over its factor).
The resulting matrix Xfg was subjected to singular value decomposition (SVD), yielding singular
values σv1 ≥ ... ≥ σvf ≥ 0 and unit-length, orthogonal, singular vectors u1, .., uf , v1, .., vf , such that
Xfg = Σi=1,..,fσvi × uif × vig. The k'th term in this sum, σvk × ukf × vkg, can explain a fraction
σvk2/Σiσvi2 of the data variance.
To reveal correlations contained in the fraction of the total variance that was not contributed by
the ﬁrst term in the SVD, we subtracted from the data matrix the values from the ﬁrst term of the
SVD, i.e., Xfg − σv1 × u1f × v1g. This resulted in a matrix of residual correlations (see Section 6,
Figure 8D). To ensure that the residual correlations were not caused by spill-over eﬀects among
neighboring genes, we used a very stringently ﬁltered set of 97 spatially well-separated genes. First,
we demanded that the distances to the nearest 'veriﬁed' or 'uncharacterized' nuclear ORF, snoRNA,
snRNA, ncRNA, CUT or SUT (according to SGD and [242]) be at least 500 bp. Second, we used
only genes whose neighboring genomic transcripts were both annotated to be transcribed from the
same strand. This way, we made sure that TSSs and pAs of neighboring transcripts were well
separated. The resulting matrix of residual correlations [146] is very similar to the one shown in
Figure 8D, conﬁrming the validity of the analysis on the full set of 4366 genes. We determined the
standard errors of each of the correlation coeﬃcients by taking bootstrap samples from the columns
of matrix Xfg − σv1 × u1f × v1g and obtained errors of ±0.047 and below. Hence, the residual
correlations are not caused by statistical noise but rather mirror actual physical and functional
associations.
48
Part III
Results and Discussion
6 Uniform transitions of the general RNA polymerase II transcrip-
tion complex
All results presented in this Section were obtained in collaboration with Andreas Mayer and
Matthias Siebert and are published in [146]. For detailed author contributions see page 9.
Gene transcription begins with the assembly of Pol II and its initiation factors on promoter
DNA. Pol II then starts mRNA synthesis and exchanges initiation factors for elongation factors,
which are required for chromatin passage and RNA processing [167, 168, 176] (for details see
Section 1). Whereas Pol II is unphosphorylated during initiation, it is phosphorylated at its CTD
during elongation. The CTD is phosphorylated at Ser5 residues in the 5´ region of a gene and at
Ser2 residues in the 3´ region [114, 199]. The phosphorylated CTD recruits elongation factors to
ensure cotranscriptional RNA processing and chromatin modiﬁcation [19, 81, 151, 167, 168, 174].
A genome-wide study has shown that initiation factors are present at all active Pol II gene
promoters [225], but it is unknown whether all elongation factors are recruited to all active genes,
and no genome-wide studies have examined whether factor recruitment correlates with speciﬁc
Pol II phosphorylations.
To address these questions, we used high-resolution genome-wide occupancy proﬁling by chromatin
immunoprecipitation (ChIP) of Pol II, its phosphorylated forms, its elongation factors and
components of the Pol II initiation and termination machinery in proliferating yeast cells. Statistical
analysis provides strong evidence for a general elongation complexthat is, one composed of all
elongation factorsthat mediates chromatin transcription and mRNA processing at all Pol II genes.
The general elongation complex is apparently established during a 5´ transition within a narrow
window just downstream of the TSS, and it is disassembled in two major steps during a 3´ transition
around the polyadenylation (pA) site. The results also show that CTD phosphorylation patterns
previously observed at individual genes occur globally and that levels of CTD phosphorylation do
not correlate with the in vivo occupancy of two factors that bind the phosphorylated CTD in vitro.
General elongation complexes are active, as their gene occupancy predicts mRNA expression levels.
6.1 Genome-wide proﬁling reveals Pol II on a majority of genes
We determined genome-wide occupancy proﬁles by ChIP in exponentially growing S. cerevisiae
strains expressing tandem aﬃnity puriﬁcation (TAP)tagged proteins. Chromatin immunoprecipi-
tation was performed as described in Sections 5.5 and 5.6. Enriched DNA fragments of an average size
of ∼250 bp were analyzed with tiling microarrays that cover the yeast genome at 4-bp resolution [44].
For data normalization, we developed a procedure that corrects for nonspeciﬁc antibody binding by
using input measurements as well as mock immunoprecipitations (Section 5.7). Data from two or
three highly reproducible replicates (R ≥ 0.8) were averaged. The ChIP-chip occupancy proﬁle for
the Pol II subunit Rpb3 (Figure 6) matched previous proﬁles [91] obtained with diﬀerent strains,
experimental protocols and array platforms, but the new proﬁle showed more details.
Pol II was observed at genes encoding proteins, small nuclear RNA and small nucleolar RNA, and
at regions producing cryptic unstable and unannotated transcripts [242], but was lacking at genes
transcribed by Pol I and Pol III (Figure 6A-C and [146]). Of 4,366 yeast genes with annotated
TSS and pA sites [159], 2,465 (56%) showed Pol II peak occupancies above 20%, consistent with
transcription of most of the genome [44]. To average Pol II proﬁles over genes, we examined the
50% most highly expressed genes [46] that were at least 200 bp away from neighboring genes. These
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were sorted into four main length classes, scaled to adjust for length diﬀerences and aligned at
their TSS and pA sites (Section 5.7.3). The pA site marks the point of RNA 3´ cleavage and
polyadenylation, but transcription continues beyond this site until termination. Consistent with
this, the gene-averaged Rpb3 proﬁle revealed Pol II occupancy through the transcribed region and
into the region ﬂanking the pA site on the 3´ side (Figure 6C).
6.2 Initiation and termination factors ﬂank the transcribed region
Gene-averaged proﬁles for the initiation factors TFIIB, TFIIF and TFIIH showed a single strong
peak 5030 bp upstream of the TSS (Figure 6D and Table 16). This indicates the presence of
initiation complexes at promoters and is consistent with a scanning mechanism for TSS location in
yeast [115, 118]. TFIIF was found only at promoters and not within transcribed regions, indicating
that its reported elongation-stimulatory activity in vitro [187] is restricted in vivo to early RNA
elongation and to downstream sites of transient association. The weaker peaks for initiation factors
observed downstream of the pA site are mostly due to residual spillover eﬀects from closely spaced
genes on the same strand. When we averaged only over convergently transcribed genes, the peaks
were reduced two- to three-fold (Figure 7). The remaining peaks may indicate gene looping at
selected genes. Occupancy of the capping enzyme subunit Cet1 peaked just downstream of the
TSS, consistent with capping when the nascent RNA appears on the Pol II surface. The symmetric
peaks of averaged occupancy of initiation factor and capping enzyme indicate that these factors are
restricted to deﬁned locations just upstream and downstream, respectively, of the TSS. Occupancy
of the 3´ processing and termination factor Pcf11 peaked downstream of the pA site, consistent
with transcription and completion of mRNA 3´-end formation downstream of the pA site. Thus,
representative initiation and termination factors show peak occupancies outside the transcribed
region and are apparently not present during mRNA chain elongation.
6.3 Elongation factors enter during a single 5´ transition
Elongation factor proﬁles did not correlate with proﬁles of initiation factors or termination
factors (Figure 8A). Elongation factors were absent at the promoter, but their occupancies sharply
increased downstream of the TSS within a narrow window of ∼50 bp, indicating coordinated
elongation complex assembly during a single 5´ transition (Figure 6E,F and Table 16). Spt16 was an
exception, entering ∼30 bp further upstream. Elongation factors showed characteristic distributions
over the transcribed region. We observed three distinct proﬁle shapes and used them to group the
factors (Figure 8B). Group 1 includes Spt4, Spt5 and Spt6, group 2 includes Spn1 and Elf1, and
group 3 includes Spt16, Paf1 and the CTD kinases Bur1 and Ctk1.
6.4 Spn1 and Elf1 interact within a Pol II complex
The similar gene-averaged proﬁles of the poorly characterized factors Spn1 and Elf1 suggested that
these factors interact. To test this, we puriﬁed Spn1 from yeast using a TAP tag. Spn1 copuriﬁed
with Elf1 and Pol II (Figure 9), consistent with an interaction between Spn1 and Elf1. To probe
for a direct Spn1-Elf1 interaction, we coexpressed the two factors in bacteria. Spn1 and Elf1 did
not copurify after coexpression (data not shown). These results suggest that Spn1 and Elf1 interact
indirectly within a Pol II complex, and the proﬁling data suggest that their recruitment and functions
during the transcription cycle are distinct from those of other elongation factors.
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Figure 6: Genome-wide occupancy
proﬁling of the Pol II machinery.
(A) Factor occupancy on selected
genes. Colored proﬁles represent nor-
malized factor occupancies smoothed
by a 150-bp window running median.
The color code is used throughout
ﬁgures. Black boxes indicate tran-
scripts [44] on the Watson (top) and
Crick strands (bottom). (B) DNA
frame with promoter, 5´ untrans-
lated region (UTR), open reading
frame (ORF) and 3´ UTR. Dashed
black lines indicate the TSS and
pA site. Dashed gray lines mark the
positions 150 bp downstream of the
TSS and 100 bp downstream of the
pA site. (C) Gene-averaged proﬁles
for the median gene length class
(1,238 ± 300 bp, 339 genes) of Pol II
and its phosphorylated forms. Pro-
ﬁles of other length classes are gen-
erally similar [146]. Occupancies and
signal intensities are given for Rpb3
and phosphorylated Pol II on the left
and right y axes, respectively. For de-
tails on ChIP-chip proﬁle calculations
see Sections 5.7.1-5.7.3. (D) Gene-
averaged proﬁles as in C for initiation
(TFIIB, TFIIF, TFIIH), 5´ capping
(Cet1) and termination (Pcf11) fac-
tors. (E,F) Gene-averaged proﬁles as
in C for elongation factors of groups 1
(Spt4, Spt5, Spt6), 2 (Elf1, Spn1)
and 3 (Spt16, Paf1, Ctk1, Bur1).
(G) Cartoon representation of Pol II
(black dots) and its CTD (black lines)
transcribing along DNA (horizontal
gray line) from left to right, to
produce mRNA (gray lines). IFs,
initiation factors; EFs 123, elongation
factors of groups 1, 2 and 3; S2/5/7P,
phosphorylation of serines 2, 5 and 7.
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Feature: Peaks around TSSa 5´ transition
(position)b
Peaks around pA site 3´ transition
(% of max)c
Genesd: M ALL M M ALL M
Pol II
Rpb3 149 ± 10 131 ± 6 −20 ± 21
S7P 26 ± 44 18 ± 21
S5P 128 ± 16 117 ± 10
S2P −252 ± 36 −204 ± 51
Initiation
TFIIB −52 ± 13 −45 ± 6
TFIIH (Kin28) −41 ± 10 −25 ± 6
TFIIF (Tfg1) −34 ± 10 −36 ± 6
5´ capping
Cet1 6 ± 18 14 ± 8
Elongation
Spt4 20 ± 13 −204 ± 16 −211 ± 12 67 ± 4
Spt5 195 ± 12 197 ± 9 15 ± 19 71 ± 6
Spt6 202 ± 12 204 ± 9 25 ± 16 75 ± 4
Elf1 26 ± 15 −73 ± 28 −74 ± 9 83 ± 3
Spn1 42 ± 15 −52 ± 28 −52 ± 9 83 ± 3
Bur1 62 ± 12 26 ± 4
Ctk1 66 ± 9 46 ± 3
Paf1 36 ± 10 29 ± 3
Spt16 −13 ± 12 21 ± 4
Termination
Pcf11 72 ± 13 58 ± 6
Table 16: Peaks and transitions of gene-averaged ChIP-chip proﬁles.
a Peak positions were determined separately for the ALL gene set (1140 genes) and length class M (339 genes).
Median proﬁles were calculated in a region ± 250 bp around the TSS or the pA site, and smoothed with
cubic splines (R package: stats, function: smooth.spline, parameter: spar = 0.9). The maximum value of
the smoothed curve was selected as peak position. To estimate the uncertainty of the peak position, we
drew 1000 bootstrap samples from the set of genes, recalculated peak positions for each bootstrap sample as
described, and estimated their scatter using the Median Absolute Deviation (MAD) measure.
b 5´ transitions were determined for length class M. Median proﬁles were calculated in a region ± 150 bp
around the TSS, and smoothed with cubic splines. The position at 11.5% occupancy of the smoothed
curve (corresponding to the point after which the elongation factor proﬁles start to change) was deﬁned as
5´ transition point. To estimate the uncertainty of the 5´ transition, we drew 1000 bootstrap samples from
the set of genes, recalculated 5´ transitions for each bootstrap sample as described, and estimated their
scatter using the MAD measure.
c 3´ transitions were determined for length class M as the percentage of the maximum occupancy at 100 bp
downstream of the pA site. Median proﬁles were calculated in a region from 250 bp upstream of the TSS
and 250 bp downstream of the pA site, and smoothed with cubic splines. To estimate the uncertainty of
the 3´ transition, we drew 1000 bootstrap samples from the set of genes, recalculated 3´ transitions for each
bootstrap sample as described, and estimated their scatter using the MAD measure.
d Gene selection to calculate gene-averaged proﬁles is described in Section 5.7.3.
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Figure 7: Gene-averaged proﬁles restricted to
convergently transcribed genes. Gene-averaged
median proﬁles for initiation (TFIIB, IIF, IIH)
factors (genes from length class M as shown
in Figure 6D) showing only convergently tran-
scribed genes (99 out of 339 genes) in order to
diminish spillover eﬀects.
6.5 Elongation factors exit during a two-step 3´ transition
Around the pA site, two steps of a 3´ transition could be distinguished. The two-step transition was
most easily seen at genes with high factor occupancies, such as ribosomal protein genes (Figure 10
and Table 16). Whereas group 3 factor occupancies sharply decreased upstream of the pA site,
factors from groups 1 and 2 apparently exited further downstream, suggesting they are present
during RNA 3´-end formation and possibly during transcription termination. Spn1 and Elf1 peaked
just upstream of the pA site, and 100 bp downstream of this site they were still present at about
80% of their peak occupancies (Figure 6E and Table 16).
6.6 A general elongation complex for chromatin transcription
High correlations between elongation factor proﬁles (Figures 8A and 11) suggested that all elongation
factors cooccupy active genes. To investigate this, we measured covariation in the data sets
by singular value decomposition (SVD, Section 5.7.6). We calculated peak occupancies for nine
elongation factors within 4,366 genes. After subtracting the row mean of the 9 Ö 4,366 matrix
from each element, we subjected the resulting matrix to SVD. The ﬁrst singular value, which
describes strict covariation, explained 92% of the total variance (Figure 8C, left, and [146]). Thus,
elongation factor occupancies covaried over all genes, consistent with a general composition of the
elongation complex. The apparent elongation complex composition and coordinated assembly during
a 5´ transition were independent of gene length, expression, function, transcript type, size of the
nucleosome-depleted promoter region and the presence of introns (Figure 12 and [146]). Although
diﬀerences in the composition of elongation complexes in individual cells cannot be ruled out,
these results indicate a general initiation-elongation transition and a general elongation complex
composition on Pol II genes.
6.7 CTD phosphorylation proﬁles depend on TSS location
To investigate how the observed proﬁles and transitions correlate with CTD phosphorylation, we
determined ChIP-chip proﬁles for Pol II phosphorylated at CTD residues Ser7, Ser5 and Ser2
using site-speciﬁc antibodies [22] (Table 10). The averaged proﬁles revealed broad peaks of Ser7
and Ser5 phosphorylation at around 20 and 120 bp downstream of the TSS (Figures 6C, 13A
and Table 16). Ser7 and Ser5 phosphorylation decreased over the transcribed region, whereas
Ser2 phosphorylation increased, saturated at 6001,000 bp downstream of the TSS and sharply
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Figure 8: Statistical analysis indicates a general elongation complex. (A) Correlation analysis of
genome-wide occupancy proﬁles. Initiation factors TFIIB, Tfg1 (TFIIF), Kin28 (TFIIH) and the capping
enzyme Cet1 have similar proﬁles that are distinct from those of the nine elongation factors and the
termination factor Pcf11. Elongation factors of groups 1, 2 and 3 (dark red, light green and blue) cluster in
two dimensions when Pearson correlation coeﬃcients between occupancy proﬁles are provided as similarity
metric (see Section 5.7.5). Lines represent direct and functional interactions previously known (gray) or
described here (black). Factors represented by ovals are not essential in yeast. (B) Pol II factors can be
grouped by their gene-averaged proﬁles. See text for details. (C) SVD analysis. The contributions of
the ﬁrst ﬁve singular vectors to the variance (red) are shown in comparison to a control with randomly
permuted matrix elements (gray). SVD reveals that 92% of the variance of peak occupancies of elongation
factors at each gene can be explained by strictly covarying factor occupancies as a contribution from the ﬁrst
singular vector (left). When all factors are included, 83.1% of the variance is explained by covariation (right).
(D) Residual correlations described by all but the ﬁrst singular vector reveal a modular substructure among
factors and phosphorylated Pol II forms, suggesting physical and functional interactions. For details on SVD
analysis see Section 5.7.6.
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Figure 9: Elf1 copuriﬁes with Spn1 and Pol II. (A) Gene-averaged proﬁles for Elf1 (orange) and Spn1 (green).
Western blotting analysis was performed to validate the TAP strains (inset). The results for the Spn1-
and Elf1-TAP strains are indicated on lane 1 and 2, respectively. The molecular weight marker is given on
lane M. (B) Spn1 TAP: the puriﬁed protein sample was analyzed by SDS-PAGE and Coomassie staining.
Spt6 could be identiﬁed by mass spectrometry. The molecular weight marker (kDA) is given on the right.
Spn1 copuriﬁes with Spt6. (C) Elf1 and Spn1 TAPs: the protein samples were analyzed by SDS-PAGE
and western blotting. The TAP strains as well as the control strain (without TAP tag) are given above the
panels. The proteins identiﬁed by western blotting are indicated on the left. Elf1 copuriﬁes with two Pol II
subunits Rpb1 and Rpb3. Spn1 copuriﬁes with Rpb3 and Elf1 bearing a C-terminally 3HA tag. For the
latter experiment, a yeast strain was generated that expressed both, a C-terminally 3HA-tagged version of
Elf1 as well as a C-terminally TAP-tagged version of Spn1. Experiments in B and C were done by Andreas
Mayer.
Figure 10: Two-step 3´ transition observed
at ribosomal protein (RP) genes. Shown are
averaged elongation factor proﬁles on selected
ribosomal protein genes (for details on gene
selection see Section 5.7.3). Dashed lines
indicate the TSS and pA sites. The regions
of the two-step 3´ transition are indicated. In
contrast to the averaged proﬁles in Figure 6,
the very high occupancies did not allow us
to align proﬁles with their promoter minima
along the y axis.
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Figure 11: Elongation factor occupancy proﬁles along chromosome 12. Representative 100 kb genome region
showing ChIP-chip occupancy proﬁles of elongation factors. Note the high degree of covariation among all
factor occupancy proﬁles.
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Figure 12: Transcription complex composition and transitions are independent of gene length, expression
and NFR size. (AC) Medians of the peak factor occupancies covary between diﬀerent length classes (A),
expression level classes (B) and nucleosome-free promoter region (NFR) size classes (C) [79, 246]. Q90%, 90%
quantiles of gene occupancies, used as a proxy for peak occupancies. (DF) Gene-averaged proﬁles of the
representative elongation factor Elf1 have shapes and transition points that are independent of gene length
(D), expression level (E) and NFR size (F). The same holds true for all other proﬁled factors and also for
genes grouped by transcript type and functional class [146].
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Figure 13: Pol II phosphorylation and factor
occupancy. (A) Gene-averaged proﬁles (for length
class L only) of CTD phosphorylations, CTD Ser5
kinase Kin28 and Ser2 kinases Bur1 and Ctk1.
(B) Proﬁles for Ser2-phosphorylated Pol II and
Pcf11 aligned at the TSS and pA site, respec-
tively, and averaged for length classes short (s),
medium (m) and long (l). Occupancy and signal
intensity for Pcf11 and S2P are plotted on the left
and right y axes, respectively. (C) Gene-averaged
proﬁles for Spt6 and the C-terminal deletion
variant Spt6ΔC (lacking the 202 C-terminal
residues) [46]. As 100% occupancy levels are
not expected for Spt6ΔC, the y axis shows ChIP
enrichments obtained by normalization with input
measurements as well as mock IPs (Section 5.7.1)
without scaling to 100% occupancy.
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decreased 100200 bp downstream of the pA site (Figures 6C, 13AB and Table 16). The point
where full Ser2 phosphorylation was reached did not depend on pA site location, but rather on TSS
location (Figure 13B). Although we cannot rule out changes in ChIP eﬃciency due to the accessibility
of the phosphorylated CTD to antibodies, our results overall indicate that CTD phosphorylation
patterns previously observed on individual genes [114, 199] occur globally and depend on TSS
location.
6.8 Recruitment of CTD kinases explains CTD phosphorylations
The Ser7 and Ser5 peaks just downstream of the TSS are consistent with the presence of the Ser7
and Ser5 kinase Kin28 [4, 110] just upstream of the TSS (Figure 13A and Table 16). Furthermore,
the early peak of Ser7 phosphorylation is consistent with dependence of Ser7 phosphorylation
on the coregulatory Mediator complex [15], which binds at promoters. The subsequent increase
in Ser2 phosphorylation is consistent with the Ser2 kinases Bur1 and Ctk1 [28, 182] entering
during the 5´ transition and remaining present in transcribed regions (Figure 13A). Thus, speciﬁc
CTD phosphorylations can be explained by the recruitment of corresponding speciﬁc CTD kinases
at deﬁned distances from the TSS. Unfortunately, we were not able to obtain satisfactory
proﬁles of CTD phosphatases to compare their recruitment with the observed decreases in CTD
phosphorylation.
6.9 CTD phosphorylation and factor recruitment
To clarify the relationships between CTD phosphorylations and factor occupancies, we subjected
all proﬁles to SVD and correlated residual proﬁles lacking the contributions of the ﬁrst SVD
term (Section 5.7.6); the eliminated ﬁrst term described 85.6% of the covariation of factor
occupancies. Ser7 and Ser5 phosphorylation correlated with the occupancy of the capping enzyme
Cet1 (Figure 8D), as expected from binding of capping enzyme to Ser5-phosphorylated CTD in
vitro [190]. As Ser5 phosphorylation levels peaked more than 100 bp downstream from the Cet1
peak, the capping enzyme may already be bound when the ﬁrst Ser5 residues are phosphorylated.
Cet1 occupancy dropped very sharply further downstream, whereas Ser5 phosphorylation levels
remained high, suggesting an active mechanism to release the capping enzyme from the CTD. Ser2
phosphorylation correlated strongly with Spn1 and Elf1 occupancy (Figure 8D), suggesting these
factors are stabilized within the elongation complex by Ser2 phosphorylation.
6.10 Possible CTD masking and CTD-independent recruitment
CTD Ser2 phosphorylation did not correlate with occupancy of Pcf11 and Spt6, although these
factors bind to the Ser2-phosphorylated CTD in vitro [6, 245]. Pcf11 was recruited mainly at the
pA site (Figure 13B), consistent with the known role of Pcf11 in RNA 3´ processing. This may be
explained if the Ser2-phosphorylated CTD becomes accessible to Pcf11 only after pA site passage and
3´ RNA cleavage. Alternatively, Pcf11 cross-linking may be increased by cooperative interactions of
factors and RNA around the pA site or by conformational changes in the elongation complex. Spt6
entered early, during the 5´ transition, suggesting a recruitment mechanism independent of CTD
Ser2 phosphorylation. To investigate this, we determined the ChIP-chip proﬁle of a variant of Spt6
lacking its CTD-binding C-terminal domain (Spt6ΔC), using a yeast strain that expresses only a
truncated Spt6 lacking the last 202 residues [46]. Deletion of the Spt6 CTD-binding domain led to
much less recruitment of Spt6 but did not abolish its entry during the 5´ transition (Figure 13C).
Thus, Spt6 is apparently recruited in a CTD-independent manner during the 5´ transition, but full
recruitment requires the CTD-binding domain. The CTD-binding domain was required for retaining
Spt6 until the pA site was reached (Figure 13C), consistent with Spt6's preference for binding the
Ser2-phosphorylated CTD. These results indicate that binding of a factor to the phosphorylated CTD
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Figure 14: Elongation complex occupancy predicts mRNA expression. (A) The logarithm of the average
elongation factor and Rpb3 transcript occupancy is highly correlated with the logarithm of mRNA levels.
For constant mRNA synthesis rates (elongation complex speeds) v and decay rates r, we expect a linear
relationship between elongation factor occupancy o and mRNA levels c, because at equilibrium the rates of
mRNA synthesis and decay are equal, and thus ov = cr. This would result in a linear dependence between
logo and logc with slope 1:logo = logc+log(r/v). The actual slope of 0.49 (green) implies that the ratio of
Pol II speed to decay rate increases slightly with increasing mRNA level (v/r ∝ c0.51). For ribosomal protein
genes, v/r is about three-fold higher than average. (B) The averaged transcript occupancy of Rpb3 and
the nine elongation factors is highly correlated with the occupancy expected on the basis of the relationship
between occupancies and observed mRNA levels in A.
in vitro cannot predict factor recruitment in vivo. This suggests that the CTD may be transiently
masked and its accessibility regulated, and that factor recruitment includes CTD-independent and
CTD phosphorylation typeindependent recruitment.
6.11 No evidence for promoter-proximally stalled Pol II
In higher eukaryotes, Pol II is often stalled early during elongation near the promoter [34, 160, 249]
and can be released by activators [185]. Our data do not provide evidence for the presence of such
promoter-proximally stalled Pol II in growing yeast. Genes with stalled Pol II would show Ser5
but not Ser2 phosphorylation, or at least more Ser5 than Ser2 phosphorylation. However, we did
not ﬁnd genes with a peak for Ser5 phosphorylation and no peak for Ser2 phosphorylation (data
not shown). SVD analysis of initiation and elongation factor proﬁles revealed a high covariance of
83.1% (Figure 8C, right, and [146]), suggesting that initiation complexes are generally eﬃciently
converted to elongation complexes. Although Rpb3 occupancy peaks around 150 bp downstream
of the TSS (Figure 6C), this does not indicate polymerase stalling, as stalling generally occurs
closer to the TSS. Instead, this Pol II peak may be explained by the 5´ transition being slow
because of capping, phosphorylation and assembly events, leading to an apparent accumulation
of Pol II. Alternatively or additionally, the peak may reﬂect transient pausing of Pol II between
the +1 and +2 nucleosomes, which are positioned around 40 and 210 bp downstream of the
TSS, respectively [94]. Our data from exponentially growing yeast also do not show evidence for
polymerase peaks upstream of the TSS, as observed in yeast during stationary growth [184].
6.12 General elongation complexes are productive
To investigate whether the general elongation complexes are active on most genes, we correlated
averaged Rpb3 and elongation factor occupancies with mRNA levels [46]. The mRNA level should
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be proportional to the mRNA synthesis rate of a single elongation complex times its occupancy,
divided by the mRNA decay rate (see legend of Figure 14). For constant mRNA synthesis and decay
rates, we would therefore expect a linear dependence of occupancy on mRNA level, corresponding
to a slope of 1 in a log-log plot. We found a robust correlation of 0.65 between the log occupancy
and the log mRNA levels (Figure 14A); however, the slope was only ∼0.5. A correlation of 0.71 was
obtained when we used the distance-ﬁltered gene set. This shows that increased mRNA levels are
due not only to greater elongation complex occupancy, but also to a higher ratio of mRNA synthesis
rates over decay rates. The same dependence leads to a high correlation of 0.79 between the observed
average occupancy and the expected occupancy calculated from the mRNA level (Figure 14B). These
correlations indicate that most general elongation complexes are active in producing mRNA and that
occupancy of genes by the general elongation complex is a good predictor for gene expression level.
6.13 Discussion & Summary
Here we have established an improved ChIP-chip protocol for obtaining high-resolution genome-wide
occupancy proﬁles for components of the Pol II transcription machinery (Sections 5.6 and 5.7),
to investigate the transcription cycle in vivo (Figure 6G). We demonstrate that Pol II elongation
factors, which are required for chromatin passage and RNA processing on individual genes, associate
with all transcribed Pol II genes in proliferating yeast cells. Elongation factors show three distinct,
nonrandom patterns of distribution over genes, and these distribution patterns are independent of
gene length, type, function or nucleosome structure. The underlying general elongation complex is
established and disassembled during uniform transitions at the beginnings and the ends of genes.
Elongation factors enter during a sharp 5´ transition just downstream of the TSS and exit in a
two-step 3´ transition around the pA site. Our genome-wide Pol II phosphorylation proﬁles match
patterns observed at individual genes and are explained by the recruitment of speciﬁc CTD kinases
at deﬁned distances from the TSS. Analysis of CTD phosphorylation proﬁles does not support
the existence of promoter-proximally stalled Pol II in growing yeast. CTD phosphorylation is
not predictive of the recruitment of factors that bind the phosphorylated CTD in vitro. Instead,
we obtained evidence that CTD accessibility is regulated by transient CTD masking and that
recruitment mechanisms are CTD independent. Finally, occupancy of genes by the general elongation
complex predicts the resulting mRNA levels, suggesting that most or all elongation complexes are
active.
Published biochemical and genetic data suggest that the 5´ transition corresponds to a coordinated
conversion of a general initiation complex to a general elongation complex. The conversion includes
initiation factor dissociation, which liberates the Pol II clamp domain [65, 141] for binding Spt5 [82].
Spt5 could coordinate entry of group 1 factors because it binds Spt4 in vitro [69] and associates with
Spt6 in vivo [130]. Group 1 factors could recruit group 2 factors, as Spt6 binds Spn1 [117, 130].
Consistent with this, group 1 factors interact genetically with Elf1 [178] and, as we show here, Spn1
and Elf1 interact within a Pol II complex. Recruitment of group 3 factors may commence with CTD
Ser5 phosphorylation; this recruits Bur1 [182], which in turn phosphorylates Spt5, thereby recruiting
Paf1 [120, 132, 254]. Spt16 enters around 30 bp upstream from other elongation factors (Figure 6F
and Table 16), perhaps because it binds to the +1 nucleosome [212]; this is consistent with its role
as a histone chaperone [10]. Initiation factors are not present when the 5´ transition is completed
around 150 bp downstream of the TSS, consistent with Ctk1 promoting dissociation of initiation
factors [2].
The general two-step 3´ transition we observed is consistent with ChIP data obtained at individual
genes. The early exit of group 3 factors Paf1, Ctk1 and Bur1, and the continued presence of
Spt4, Spt5 and Spt6, have previously been observed [103, 108]. Our results, however, show that
the reported Spt16 occupancy downstream of the pA site [108] does not occur globally. Also, our
observation of peak levels of the bona ﬁde 3´ processing factor Pcf11 downstream of the pA site
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challenges the idea of an early loading of 3´ processing factors in the 5´ region of genes [64]. We
observed continued presence of group 1 and group 2 factors downstream of the pA site, consistent
with their reported roles in mRNA 3´ processing [100], mRNA export [245] and re-establishment of
chromatin structure after Pol II passage [101].
Our results also provide insights into the role of CTD phosphorylation during transcription complex
transitions and in the coordination of transcription-coupled events. First, peak levels of Ser7
and Ser5 phosphorylation were generally observed in the 5´ regions of genes, and peak Ser2
phosphorylation in the 3´ regions of genes. Second, the 5´ transition occurs before any substantial
Ser2 phosphorylation, suggesting that the assembly of the general elongation complex is independent
of Ser2 phosphorylation, consistent with the observation that the Ser2 kinase Ctk1 is not required
for association of elongation factors with transcribing Pol II [3]. Third, peak levels of Ser2
phosphorylation are always reached 6001,000 bp downstream of the TSS, regardless of the position
of the pA site. This argues against a role of Ser2 phosphorylation in triggering the 3´ transition,
although Ser2 phosphorylation is required for cotranscriptional 3´ RNA processing [3]. Fourth, the
recruitment of Pcf11 and Spt6, which both bind the Ser2-phosphorylated CTD in vitro, cannot be
explained solely by factor binding to the Ser2-phosphorylated CTD in vivo. Instead, late Pcf11
entry suggests CTD masking within the transcribed region and an increase in CTD accessibility
upon RNA cleavage at the pA site, allowing for Pcf11 binding. Furthermore, Spt6 enters during
the 5´ transition even when it lacks its CTD-binding domain, indicating that a CTD-independent
recruitment mechanism exists. The CTD-binding domain seems to be more important for retaining
Spt6 until the pA site is reached than for recruiting it during the 5´ transition.
In conclusion, our data support the following view of a productive transcription cycle. The initiation
complex forms ∼3050 bp upstream of the TSS and contains unphosphorylated Pol II and initiation
factors. The complex then scans for the TSS downstream, begins RNA synthesis and triggers RNA
5´ capping. Next, the complex is converted into a general elongation complex during a sharp and
eﬃcient but presumably slow 5´ transition that is completed around 150 bp downstream of the
TSS, where Ser5 phosphorylation levels peak. During subsequent elongation, Ser2 phosphorylation
increases until it reaches peak levels 6001,000 bp downstream of the TSS. During a two-step
3´ transition, a group of elongation factors exits upstream of the pA site, whereas another group
persists downstream, where it is joined by additional factors such as Pcf11, resulting in mRNA
3´ processing and transcription termination.
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7 Cap completion and CTD kinase recruitment underlie the
initiation-elongation transition of RNA polymerase II
All results presented in this Section are published in [128].
Transcription of protein-coding genes by RNA polymerase (Pol) II begins with the assembly
of an initiation complex at the promoter. As the RNA grows, initiation factors dissociate from
Pol II, and elongation factors are recruited [167, 168, 176] (for details see Section 1). The
initiation-elongation transition begins when the nascent RNA grows to about 12 nucleotides (nt),
which releases initiation factor TFIIB [169, 194]. Release of initiation factors frees the Pol II clamp
domain, which binds the conserved elongation factor Spt5 [65, 141]. Here we refer to the exchange
of initiation by elongation factors as initiation-elongation transition. The transition starts with the
dissociation of initiation factors, and ends with completed recruitment of elongation factors.
During initiation, the C-terminal repeat domain (CTD) of Pol II gets phosphorylated at residue
serine 5 (S5) and S7 [19, 86, 174]. CTD S5 phosphorylation is important for recruitment
of RNA 5´-capping enzymes [114, 149, 199]. Capping starts with removal of the terminal
γ-phosphate from the 5´-triphosphate end of the nascent RNA, which is catalysed by the RNA
triphosphatase [35, 59, 203]. The truncated RNA 5´-end is then linked to an inverted guanylyl
group by the guanylyltransferase. Finally, the cap methyltransferase methylates position N7 of
the newly added terminal guanine. In S. cerevisiae the three catalytic activities are encoded by
Cet1, Ceg1 and Abd1, respectively. In metazoans the ﬁrst two steps of the capping reaction are
catalyzed by a single capping enzyme consisting of a N-terminal triphosphatase and a C-terminal
guanylyltransferase domain. The resulting 7-methyl-guanosine (m7G) cap protects the transcript
from degradation and promotes translation initiation of the mRNA [201, 208]. The complete cap
associates with the cap-binding complex (CBC) that functions in pre-mRNA splicing and mRNA
export [125, 202].
We have previously obtained high-resolution genome-wide occupancy proﬁles for Pol II initiation
and elongation factors by chromatin immunoprecipitation (ChIP) in S. cerevisiae (Section 6). This
study showed that initiation factor occupancy peaked around 50 bp upstream of the transcription
start site (TSS) (Section 6.2), consistent with recent nucleotide-resolution ChIP-exo studies [188].
Exchange of Pol II initiation factors by elongation factors mainly occurred within 150 bp downstream
of the TSS (Section 6.3). Further downstream, CTD phosphorylation levels decreased at residues
S5 and S7, and increased at residues S2 (Section 6.7). S2 phosphorylation is achieved by the CTD
kinases Bur1 [182] and Ctk1 [28] that enable eﬃcient RNA elongation and 3´-processing [3, 103].
The mechanisms to recruit these elongation-promoting kinases are poorly understood, although
recent work showed that Bur1 recruitment is stimulated by its C-terminal region that binds the
S5-phosphorylated CTD [182].
Bur1 and Ctk1 share homology with mammalian Cdk9, the kinase of the P-TEFb complex which
triggers the transition into productive elongation [25, 140, 163]. For a long time it was believed
that Cdk9 is the major contributor to S2 phosphorylation in higher eukaryotes, but recent evidence
suggests that the ﬂy and human Cdk12 proteins also contribute to S2 phosphorylation, and that
Bur1 and Ctk1 might be the orthologs of Cdk9 and Cdk12, respectively [7]. P-TEFb can release
Pol II from promoter-proximal pause sites by phosphorylating the CTD, DSIF (human Spt4-Spt5)
and NELF (negative elongation factor), leading to dissociation of NELF and transformation of
DSIF into a positive elongation factor [1, 244]. While most of the key players controlling the
initiation-elongation transition are conserved between S. cerevisiae and higher eukaryotes, yeast
and C. elegans apparently lack a NELF ortholog and promoter-proximal pausing.
Human Cdk9 physically interacts with the CBC [124], and Cdk9 from the ﬁssion yeast S. pombe
interacts with the cap methyltransferase [68, 209]. Further, Spt5 interacts with human, S. cerevisiae
and S. pombe capping enzymes [130, 173, 198, 230]. These interactions have led to a capping
63
checkpoint model which suggests that Pol II pauses near the TSS to allow for co-transcriptional
capping before entering productive elongation [139, 168, 172, 173].
The relevance of these interactions for the recruitment of the capping machinery and early elongation
factors to transcribed genes has not been studied genome-wide in vivo. To address this we extended
our ChIP-chip occupancy proﬁling to capping enzymes and the CBC. We found that the ﬁrst
two capping enzymes, Cet1 and Ceg1, are recruited near the TSS, whereas the third enzyme, the
methyltransferase Abd1, is recruited about 110 bp downstream of the TSS, and CBC is recruited
further downstream. We report that capping enzyme recruitment requires the C-terminal region
(CTR) of Spt5 and that Bur1 helps to release capping enzymes from Spt5 once capping is completed.
Moreover we show that Abd1 and CBC are involved in the recruitment of Ctk1 and Bur1 in vivo,
thus maintaining proper levels of S2-phosphorylated Pol II and elongation factors.
A recent study showed that gene recruitment of Bur2 and Ctk2, the cyclin partners of Bur1 and Ctk1,
respectively, required the CBC, and that the kinase complexes interacted with the CBC [85]. This
study also demonstrated an eﬀect of CBC deletion on S2 phosphorylation. Our data are consistent
with these ﬁndings but also provide additional insights that lead to a model for factor exchange
during the initiation-elongation transition of Pol II that supports the capping checkpoint model and
has implications for understanding the promoter-proximal transition in higher cells.
7.1 Involvement of the Spt5 CTR in recruitment of capping enzymes
Spt5 may help to recruit capping enzymes to transcribed genes, since it copuriﬁes with Cet1, Ceg1,
and Abd1 [130]. In vitro, Spt5 binds and activates the human capping enzyme [230], and its C-
terminal repeat region (CTR) binds S. pombe triphosphatase and guanylyltransferase [173, 198]. To
test whether Spt5 is involved in recruiting capping enzymes in vivo, we carried out ChIP analysis
in S. cerevisiae strains expressing only Spt5 lacking the CTR [132, 147]. We detected a decrease in
occupancy of Cet1, Ceg1, and Abd1 to about 65%, 50%, and 35% of wild-type levels, respectively, at
the 5´ region of the ADH1 gene, whereas Pol II occupancy was relatively unaﬀected (Figure 15A).
Similar results were obtained for ACT1 (Figure 16A). Total protein levels of Cet1, Ceg1, and Abd1
remained unchanged in the CTR deleted cells (Figure 16B). These results show that substitution
of Spt5 with a mutant lacking the CTR reduces occupancy of capping enzymes over the ADH1
and ACT1 genes. Since S5 phosphorylation of the CTD by the initiation factor TFIIH kinase
Kin28 (human Cdk7) is also required for capping enzyme recruitment [114, 149, 199], these results
suggest that the Spt5 CTR and the Pol II CTD both contribute to ensure full recruitment of capping
enzymes to the 5' region of genes in vivo.
7.2 The Bur1 kinase complex promotes release of capping enzymes
We demonstrated that deletion of the CTR of Spt5 reduced Abd1 occupancy at the 5' region
of ADH1 and ACT1, but not further downstream (Figures 15A and 16A), suggesting that Abd1
is released from Spt5 during the initiation-elongation transition. Since the elongation-promoting
kinase complex Bur1-Bur2 phosphorylates the Spt5 CTR during this transition [132, 254], Bur1
may help to release capping enzymes from Spt5 after cap completion. To investigate this we carried
out ChIP analysis of Cet1 and Abd1 in a strain lacking Bur2, the cyclin subunit of the Bur1
complex (Figure 15B and C). In the bur24 mutant phosphorylation of Spt5 is reduced [254]. Cet1
and Abd1 occupancies were normalized against Pol II occupancy since Bur2 deletion had a negative
eﬀect on Pol II recruitment (Figure 15B). We found that deletion of Bur2 led to a signiﬁcant
increase (∼2 fold) of Abd1/Pol II ratios at the ORF and 3' regions of ADH1, ACT1, and ILV5
(Figures 15B and 16C). For Cet1 we observed a similar increase in Cet1/Pol II ratios, suggesting
that residual amounts of Cet1 molecules remain associated with the transcription complex until the
3' end of genes when Bur2 is deleted (Figures 15C and 16D). At the ADH1 gene the Cet1/Pol
II ratio was also increased at the 5' region (Figure 15C). We do not know the reason for this
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Figure 15: The Spt5 CTR is involved in recruitment of capping enzymes. ChIP-qPCR analysis was
performed to monitor capping enzyme and Pol II recruitment at three diﬀerent gene regions of ADH1 :
TSS (5´), coding (ORF, open reading frame) and terminator region (3´). Occupancies were calculated
as fold enrichments over an ORF-free untranscribed region on chromosome V and are indicated on the
y axes (see Section 5.5.4). Error bars show SD from three independent experiments of biological replicates,
and the asterisk (*) indicates if the factor occupancies are signiﬁcantly diﬀerent (p-value < 0.05) between
the wild-type and mutant condition using Student's t-test. (A) Cet1, Ceg1, Abd1 and Pol II occupancies for
wild-type (black bars) compared to Spt54CTR (gray bars) cells are shown. (B) Abd1 and Pol II occupancies
for wild-type (black bars) compared to bur24 (gray bars) cells are shown. Abd1 fold enrichments relative to
Pol II (Abd1/Pol II) were calculated by dividing Abd1 occupancies by Pol II occupancies. (C) Occupancies
as in B for Cet1. (D) Cet1/Pol II and Abd1/Pol II ChIP signals for the ORF region of ADH1 relative to the
5' end.
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Figure 16: The Spt5 CTR is involved in recruitment of capping enzymes. (A, C-E) ChIP-qPCR analysis
was performed as described in Figure 15 to monitor capping enzyme and Pol II recruitment at diﬀerent gene
regions of ACT1 and ILV5. (B) Western blot analysis showing equal levels of Cet1-TAP, Ceg1-TAP and
Abd1-TAP in wild-type and Spt5ΔCTR cells under normal growth conditions. 40 μg of total protein were
loaded from each strain. Pgk1 is included as an internal loading control.
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increase, but to check whether the Cet1/Pol II increase at the ORF region is an indirect eﬀect
due to higher levels at the 5' region we compared the ORF/5' ChIP ratio between wild-type and
bur24 experiments. In wild-type, the Cet1/Pol II ratio decreased from 100% (5') to 3.9% (ORF),
while in bur24 it decreased to 9.5% (ORF) (Figure 15D). Likewise decreased the Abd1/Pol II ratio
from 100% (5') to 18.8% (ORF) in wild-type, and to 48.8% (ORF) in bur24 cells. Similar eﬀects
were seen at other tested genes (Figure 16E). Overall these results support a model in which the
Bur1-Bur2 kinase complex helps to release capping enzymes from Spt5, maybe by phosphorylating
the CTR [132, 254].
7.3 Cet1-Ceg1 recruitment is restricted to the TSS
To determine the regions of capping enzyme recruitment to DNA at high resolution we
collected genome-wide occupancy proﬁles for capping enzymes by ChIP-chip in exponentially
growing S. cerevisiae culture. ChIP-chip and data analysis were performed as described in
Sections 5.6 and 5.7, respectively. Averaging of ChIP proﬁles after alignment of genes at their
TSS [159] revealed a sharp peak for Ceg1 (Figure 17A and B, upper panel) ∼20 bp downstream of
the TSS. The peak location and shape were virtually identical to that for Cet1 (Figure 17A and B,
upper panel, and Section 6.2). Both peaks were independent of gene length, gene type or expression
level [128]. The highly similar proﬁles for Cet1 and Ceg1 (R = 0.93) are consistent with the formation
of a stable Cet1-Ceg1 heterodimer [66], and conﬁrm the high resolution of our occupancy proﬁling.
Cet1-Ceg1 occupancy increases and decreases sharply, with a peak width similar to that obtained
for the initiation factor TFIIB (Section 6.2) that binds a deﬁned promoter region (Figure 17A
and B, lower panel). Thus the recruitment and activity of the Cet1-Ceg1 heterodimer is apparently
restricted to a narrow window near the TSS. Although ChIP data reﬂect only physical presence of
proteins, and although cross-linking can be indirect via other proteins, these results are consistent
with the model that the ﬁrst two capping reactions occur on the polymerase surface when the nascent
RNA 5'-end emerges from the Pol II RNA exit channel.
7.4 Abd1 recruitment occurs downstream of Cet1-Ceg1
ChIP-chip proﬁling of the third capping enzyme, the methyltransferase Abd1, revealed a strong
peak ∼110 bp downstream of the TSS, about 90 bp further downstream from the peak for Cet1-
Ceg1 (Figure 17A and B, upper panel). This separation of occupancy peaks for Cet1-Ceg1 and
Abd1 is highly signiﬁcant and independent of gene length, gene type or expression level (Figure 18
and [128]). A separation of occupancy peaks was also visible for the Cet1-Ceg1 dimer and the
initiation factor TFIIB, which is located ∼70 bp upstream of Cet1-Ceg1 (compare Figure 17A upper
and lower panel), a location that was conﬁrmed by nucleotide-resolution ChIP-exo data [188]. The
Abd1 proﬁle is very similar to the proﬁle for S5-phosphorylated Pol II (R = 0.75), and the peaks of
both proﬁles are at the same position (Figure 17A and B, upper panel). This is consistent with Abd1
binding to the S5-phosphorylated CTD in vitro [149]. These results suggest that cotranscriptional
pre-mRNA capping occurs in two steps, triphosphatase/guanylyltransferase action and methylation,
and that completion of the cap by methylation is likely a spatially separated event that occurs around
110 bp downstream of the TSS.
7.5 Spt5 is involved in Abd1 recruitment genome-wide
We demonstrated that full Abd1 recruitment to the 5' region of ADH1 and ACT1 requires the
Spt5 CTR (Figures 15A and 16A). To further investigate whether deletion of the Spt5 CTR has
an eﬀect on Abd1 occupancy genome-wide, we carried out ChIP-chip proﬁling of Abd1 in cells
expressing only Spt5 lacking the CTR. We performed metagene analysis and detected a decrease
in Abd1 occupancy across the 5' region of genes (Figure 17C, upper panel). Clustering analysis
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Figure 17: Genome-wide occupancy proﬁling of the capping machinery. (A) Gene-averaged ChIP-chip
proﬁles for capping enzymes and Pol II phosphorylated at serine 5 (S5P) residues of the CTD (upper panel),
and for initiation factor TFIIB, CBC subunit CBP20, and elongation factors Bur1, Ctk1 and Spt5 (lower
panel). Proﬁles in the lower panel were described in Section 6, except for CBP20. The proﬁle of the other
CBC subunit, CBP80, looks similar than CBP20 but shows much lower signals [128]. Occupancy proﬁles
taken from the quality-ﬁltered ALL gene set (1140 genes) were cut around the TSS (from 250 bp upstream
to 650 bp downstream; only genes longer than 680 bp were considered) and averaged using a 5% trimmed
mean at each genomic position. Proﬁles for gene length classes are similar [128]. Dashed gray lines mark the
peak positions of the averaged ChIP-chip proﬁles. For details on ChIP-chip proﬁle calculation see Section 5.7.
(B) Gene-averaged ChIP-chip proﬁles as in A but for medium length genes (1238 ± 300 bp, n = 339). Genes
were aligned at their TSS and pA sites [159], scaled to median length, and averaged using a 5% trimmed
mean at each genomic position. Proﬁles of other gene length classes are similar [128, 146]. (C) Gene-averaged
ChIP-chip proﬁles as in A for Abd1 in wild-type compared to Spt54CTR cells (upper panel) and for Bur1
(lower panel). The dashed grey line marks the position were full recruitment of Bur1 is reached ∼250 bp
downstream of the TSS.
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Figure 18: Capping enzyme proﬁle peak distances are independent of expression level and gene length.
(A) Gene-averaged proﬁles for Ceg1 and Abd1 for genes in three expression level classes. The quality-ﬁltered
set of medium length genes (Figure 17B) was partitioned into three groups: low (25%-50% quantile),
medium (50%-75% quantile), and high (>75% quantile) expression levels [46]. (B) Box plots showing
the gene-wise variation of peak distances between Cet1 and Abd1 for short (725 ± 213 bp, n = 266),
medium (1238 ± 300 bp, n = 339), and long (2,217 ± 679 bp, n = 299) genes (Section 5.7). Mean distances
are indicated by ﬁlled black circles. The distribution of peak distances between Ceg1 and Abd1 is similar (not
shown).
revealed that the eﬀect is of general nature and observed at most genes (not shown). The main
diﬀerences in Abd1 occupancy between wild-type and Spt54CTR backgrounds were restricted to a
region from upstream of the TSS to ∼250 bp downstream (Figure 17C, upper panel), consistent with
our ChIP data at ADH1 and ACT1 (Figures 15A and 16A). Bur1 occupancy is low around the TSS
and increases further downstream with peak occupancy also reached ∼250 bp downstream of the
TSS (Figure 17C, lower panel). This is consistent with the model that the Bur1-Bur2 kinase complex
promotes release of capping enzymes from Spt5 (Figures 15B  D and 16C  E). Taken together our
ChIP-chip results indicate that the requirement of Spt5 for full Abd1 recruitment occurs globally
and is restricted to the 5' region of genes where Bur1 occupancy is low.
7.6 Recruitment of the cap-binding complex
The above data suggested that the cap structure can generally only be completed around 110 bp
downstream of the TSS, where peak occupancies of Abd1 were observed. If true, then recruitment
of the cap-binding complex (CBC), which binds the complete cap and interacts directly with the
N7 methyl group in vitro [21, 148], should occur only from this point on downstream. Indeed, ChIP-
chip proﬁling revealed that the two CBC subunits CBP20 and CBP80 are recruited around 110 bp
downstream of the TSS and show full occupancy from 200-300 bp downstream onwards (Figure 17A
and B, lower panel, and [128]). CBP20 showed higher signals than CBP80, probably since it contains
the cap-binding site. CBC occupancy drops sharply just upstream of the pA site. This is consistent
with release of the CBC-containing mRNA from DNA after 3´ RNA cleavage that occurs upon
polymerase passage over the pA site. These results indicate that direct binding to the complete
m7G cap dominates CBC recruitment to active genes in vivo.
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7.7 Involvement of CBC in recruitment of kinases Bur1 and Ctk1
The CBC subunit occupancy proﬁles resembled those of the CTD kinases Bur1 and Ctk1, which are
also released before the pA site (Figure 17A and B, lower panel, and Section 6.5). Since binding
of these kinases is generally completed 200-300 bp downstream of the TSS, we wondered whether
cap completion and CBC binding trigger Bur1 and Ctk1 recruitment in vivo. We carried out ChIP
analysis of Bur1 and Ctk1 in knock-out strains lacking CBP20 (Figure 19), in which the CBC-cap
complex is disrupted [239]. In cbp204 strains, Bur1 occupancy was decreased up to 50% of wild-type
levels throughout the ADH1 and PMA1 genes (Figure 19). The reduction in kinase occupancy was
not due to a diﬀerence in Pol II occupancy (Figure 19), consistent with the ﬁnding that the CBC
does not aﬀect Pol II processivity [239]. In contrast, CBP20 deletion did not aﬀect Ctk1 recruitment
to the 5' region of ADH1 and PMA1, but reduced Ctk1 occupancy in the central and the 3' region
of the genes (Figure 19). Taken together, these results demonstrate that the CBC is required for
normal recruitment of the CTD kinase Bur1 to active genes and for maintaining high occupancy of
Ctk1 further downstream.
7.8 Role of CBC in CTD S2 phosphorylation and elongation factor recruitment
Since Bur1 and Ctk1 phosphorylate S2 residues of the Pol II CTD [28, 182], we suspected that CBP20
deletion would aﬀect levels of S2-phosphorylated Pol II and elongation factor recruitment. To test
this we performed ChIP experiments using speciﬁc antibodies that recognize the S2-phosphorylated
CTD. As expected, deletion of CBP20 led to a two-fold decrease of S2 phosphorylation levels in the
central and 3' region of the ADH1 and PMA1 genes (Figure 19). Also, CBP20 deletion aﬀected
downstream occupancy with the Pol II elongation factors Elf1, Spn1, and Spt6 (Figure 19 and [128]),
the latter of which binds the S2-phosphorylated CTD in vitro [213]. Moreover, genome-wide
occupancy of Elf1 and Spn1 correlates with S2 phosphorylation levels (Section 6.9). Elongation
factor Spt4 was reduced at the 3' region of ADH1 but not PMA1, and elongation factors Spt5
and Spt16 were unaﬀected [128]. Thus proper Bur1 and Ctk1 recruitment by CBC is crucial for
maintaining high levels of S2-phosphorylated Pol II and elongation factors.
7.9 Abd1 contributes to Bur1 and Ctk1 recruitment
To further investigate a role for capping in recruitment of the CTD kinases Bur1 and Ctk1
in vivo, we conditionally depleted the essential Abd1 methyltransferase from the nucleus using
the anchor-away (AA) method [76]. Abd1 was tagged with the FKBP12-rapamycin binding (FRB)
domain and depleted from the nucleus upon rapamycin treatment by its anchoring to FKBP12 that
was fused to the ribosomal protein RPL13A. Strains expressing Abd1-FRB from the endogenous
ABD1 promoter grew normally, but rapamycin addition induced a growth defect (Figure 21A). To
conﬁrm nuclear depletion of Abd1, we tagged the Abd1-FRB fusion protein with GFP and monitored
ﬂuorescence upon rapamycin treatment. Abd1-FRB-GFP was exclusively located in nuclei, and
rapamycin treatment led to cytoplasmic ﬂuorescence (Figure 21B), as expected.
Nuclear depletion of Abd1 decreased Bur1 occupancy at the ADH1 and PMA1 genes (Figure 20),
as observed upon CBP20 deletion (Figure 7.7). This suggested that a lower level of cap completion
could have led to reduced CBC binding and thus reduced Bur1 recruitment. Consistent with this,
CBP20 occupancy was reduced to about 40% throughout PMA1 and in the central and 3' region
of ADH1 upon nuclear depletion of Abd1 (Figure 20). Moreover, Abd1 depletion reduced Ctk1
recruitment to the central and 3' regions of ADH1 and PMA1 by ∼50% (Figure 20). In addition,
Ctk1 occupancy was also decreased at the 5' region of PMA1 upon Abd1 depletion, but was
unaﬀected by CBP20 deletion (compare Figures 20B and 19B). Changes in ChIP signals did neither
originate from diﬀerences in Pol II occupancy (Figure 20) nor from rapamycin treatment (Figure 22).
Total protein levels of Bur1 and Ctk1 remained unchanged upon Abd1 depletion [128]. Taken
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together, the cap methyltransferase Abd1 is important for recruitment of CBC and maintaining
normal levels of the CTD kinases Bur1 and Ctk1.
Figure 19: CBP20 is involved in recruitment of the kinases Bur1 and Ctk1. ChIP-qPCR analysis was
performed to monitor changes in elongation factor and Pol II recruitment upon CBP20 deletion. Changes
in levels of Ser2 phosphorylated Pol II CTD (S2P) were also analyzed. Three gene regions of (A) ADH1
and (B) PMA1 were investigated. Occupancies for wild-type (black bars) compared to cbp204 (gray bars)
cells are shown. Occupancies were calculated as fold enrichments over an ORF-free untranscribed region on
chromosome V and are indicated on the y axes (see Section 5.5.4). Error bars show SD from at least three
independent experiments of biological replicates, and the asterisk (*) indicates if the factor occupancies are
signiﬁcantly diﬀerent (p-value < 0.05) between the wild-type and mutant condition using Student's t-test.
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Figure 20: Abd1 contributes to recruitment of the CBC, Bur1 and Ctk1. ChIP-qPCR analysis was
performed to monitor changes in Bur1, Ctk1, CBP20 and Pol II recruitment upon Abd1 nuclear depletion
using the anchor-away technique. Changes in levels of Ser2 phosphorylated Pol II CTD (S2P) were
also analyzed. Three gene regions of (A) ADH1 and (B) PMA1 were investigated. Occupancies in the
Abd1-anchor-away strain that was not (black bars) or was (gray bars) treated with rapamycin for 60 min
are indicated. Occupancies were calculated as fold enrichments over an ORF-free untranscribed region on
chromosome V and are indicated on the y axes (see Section 5.5.4). Error bars show SD from at least three
independent experiments of biological replicates, and the asterisk (*) indicates if the factor occupancies are
signiﬁcantly diﬀerent (p-value < 0.05) between the treated and untreated condition using paired samples
Student's t-test.
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Figure 21: Rapamycin treatment leads to nuclear depletion of Abd1 and causes growth delay. (A) Spot
dilution assay on YPD plates in the absence or presence of 1µg/ml rapamycin. The parental strain HHY168
was used as negative control. Dilutions were 10-fold. (B) GFP ﬂuorescence of Abd1-FRB-GFP cells incubated
without or with rapamycin (1µg/ml in DMSO) for 60 min. Addition of rapamycin causes depletion of
Abd1-FRB-GFP from the nucleus.
Figure 22: Rapamycin treatment does not aﬀect Bur1 or Ctk1 occupancy at ADH1 (A) or PMA1 (B)
using control strains expressing only untagged Abd1. ChIP-qPCR analysis was performed to monitor Bur1
and Ctk1 recruitment at the indicated gene regions. Occupancies in the anchor-away parental strain that
was not (black bars) or was (gray bars) treated with rapamycin for 60 min are shown. Fold enrichments over
an ORF-free untranscribed region on chromosome V are indicated on the y axes (see Section 5.5.4). Error
bars show SD from three independent experiments of biological replicates.
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7.10 Discussion & Summary
We previously observed that genome-wide ChIP occupancy proﬁles for yeast transcription initiation
and elongation factors are not overlapping, consistent with exchange of factors during a general
initiation-elongation transition (Section 6). Here we show that this transition and factor exchange
involves stepwise recruitment of proteins that form and recognize the RNA 5´-cap structure. We
ﬁrst analyzed the occupancy of cap-forming and cap-binding proteins on active Pol II genes, and
then investigated how formation of a complete cap triggers the recruitment of elongation-promoting
kinases Bur1 and Ctk1.
In the ﬁrst part of this work, we found that the RNA triphosphatase Cet1 and the guanylyltransferase
Ceg1 have virtually identical occupancy proﬁles with a sharp peak ∼20 bp downstream of the TSS.
This is consistent with the existence of a stable Cet1-Ceg1 heterodimer in fungi [66] and the presence
of both activities within a single enzyme in metazoa [83]. Occupancy for the cap methyltransferase
Abd1 was clearly distinct and peaked ∼110 bp downstream of the TSS. This is consistent with
earlier studies, also showing a signiﬁcant lag from guanylylation to methylation using a functionally
coupled human in vitro transcription/capping system [27, 157]. Thus, whereas Cet1 and Ceg1 are
obviously recruited in a single step and are present only near the TSS, Abd1 is recruited further
downstream, and can remain until the 3´-end of genes, consistent with ChIP data at individual
genes [199]. Abd1 recruitment apparently leads to cap completion immediately downstream, because
the cap-binding complex reaches full occupancy levels about 200-300 bp downstream of the TSS,
supporting the hypothesis that the methylated cap recruits CBC to nascent mRNA in yeast [239].
We further demonstrated that full capping enzyme recruitment requires the CTR of Spt5. Since our
genome-wide ChIP-chip data revealed that the main peak for Spt5 occupancy lies downstream of the
capping enzyme peaks, we suggest that the capping factors are loaded onto the Pol II machinery ﬁrst
via binding to the S5-phosphorylated CTD [114, 149, 199] and that this association is subsequently
stabilized by Spt5.
In the second part of our work we found that cap completion is coupled to the recruitment of
the kinases Bur1 and Ctk1. These yeast enzymes share homology with mammalian Cdk9, the
kinase subunit of the P-TEFb complex that triggers the transition into productive transcription
elongation [25, 140, 163]. Normal Bur1 and Ctk1 recruitment to active genes, and thus proper
S2 phosphorylation levels of Pol II, required Abd1 and CBC. The CBC and its eﬀect on CTD S2
phosphorylation were also important for maintaining high levels of elongation factors. Recruitment
of Bur1 additionally depends on binding the S5-phosphorylated CTD [182], suggesting that CBC
and the CTD cooperate for Bur1 recruitment. Since Bur1 also phosphorylates the Spt5 CTR [132],
and since we show here that the Spt5 CTR contributes to capping enzyme recruitment, Bur1 may
help to release capping enzymes from Spt5 after cap completion. This is consistent with our ﬁnding
that Abd1 occupancy downstream of Bur1 recruitment was unaﬀected by CTR deletion. In addition,
we demonstrated that Bur2 deletion leads to increased Cet1 and Abd1 occupancies along the gene
bodies of ADH1, ACT1, and ILV5, further supporting our model.
Our ﬁndings agree with published results that showed physical interactions between the capping
machinery and early elongation factors [68, 124, 130, 173, 198, 230]. In addition, a recent study
showed that gene recruitment of Bur2 and Ctk2, the cyclin partners of Bur1 and Ctk1, respectively,
required the CBC [85]. Furthermore this study demonstrated an eﬀect of CBC deletion on S2
phosphorylation. Our data are consistent with these ﬁndings but also provide additional insights
that lead to a more complete model for factor exchange during the initiation-elongation transition
of Pol II. All available results support a previously proposed capping-dependent checkpoint during
early elongation [139, 168, 173, 172].
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Figure 23: Model for the Pol II initiation-elongation transition. Pol II and its CTD (black) transcribe
DNA (horizontal black line) from left to right to produce capped mRNA (gray). PIC, preinitiation complex;
EC, elongation complex; IIA/B/D/E/F/H, initiation factors; S2/5P, phosphorylated serine 2 and 5 residues;
m7, N7 methyl group of the cap; Paf1C, Paf1 complex. For details see text.
From these studies emerges the following model for the initiation-elongation transition (Figure 23).
During initiation, the growing RNA transcript triggers initiation factor dissociation, which liberates
the Pol II clamp domain for binding Spt5 [65, 141]. The S5-phosphorylated CTD stimulates
recruitment of capping enzymes to Pol II [114, 149, 199] and this association is subsequently
stabilized by the CTR of Spt5. When the nascent RNA appears on the Pol II surface, it receives an
inverse GMP moiety by the action of the Cet1-Ceg1 heterodimer. Rapid dissociation of Cet1-Ceg1
gives way to the cap methyltransferase Abd1, which is recruited downstream and can remain with
partially S5-phosphorylated elongating Pol II. Abd1 and the S5-phosphorylated CTD [182] initially
recruit Ctk1 and Bur1, respectively. The cap is completed by methylation and binds CBC, which
ensures high occupancy for both Ctk1 and Bur1 when levels of Abd1 and S5 phosphorylation
drop downstream. Nascent RNAs with unmethylated cap structures are removed by the Rai1-Rat1
decay pathway [95]. Bur1 phosphorylates promoter-proximal CTD S2 residues and the Spt5 CTR,
promoting release of capping enzymes. This facilitates recruitment of the Paf complex [132, 181, 182],
which establishes histone modiﬁcations linked to active transcription [90]. Ctk1 phosphorylates S2
residues of the CTD further downstream [28, 182] and stimulates Pol II association with elongation,
chromatin-modifying and RNA-processing factors [112, 150, 213], resulting in a productive elongation
complex. Because recent evidence indicates that Bur1 is the P-TEFb (Cdk9) homologue [7], the
same events likely occur during the initiation-elongation transition in higher cells.
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8 CTD tyrosine dephosphorylation underlies the elongation-
termination transition of RNA polymerase II
This Section presents ChIP-chip data that I analyzed during several collaborations. All results
presented in Sections 8.1 to 8.3 are published in [145] and [147]. All results presented in Section 8.4
are in the process of publication. For detailed author contributions see page 9.
During the transcription cycle, CTD phosphorylation patterns coordinate the recruitment of
transcription and mRNA processing factors to Pol II [19, 23, 33] (for details see Section 1.2.1).
During early transcription, Ser5 phosphorylation recruits the mRNA capping enzymes [114, 199].
Ser2 phosphorylation occurs during elongation and functions in recruitment of 3´ RNA processing
and termination factors [3]. Phosphorylation at Ser7 [52] and Thr4 [87] has roles in processing of
speciﬁc RNAs. Tyr1 phosphorylation was described for human Pol II almost two decades ago [8],
but whether this has a functional role and whether it exists in other species is unknown.
Two major transitions occur during the Pol II transcription cycle, the initiation-elongation transition
at the 5´ ends of genes and the elongation-termination transition at the 3´ ends of genes (Section 6).
These transitions are coupled to 5´ RNA capping and 3´ RNA processing, respectively (for details
see Section 1.2). Whereas the ﬁrst transition has been extensively studied by us (Section 7) and
others [2, 57, 114, 121, 136, 176], less is known about the second transition. Studies of the second
transition revealed a role of the Ser2-phosphorylated Pol II CTD in the recruitment of 3´-end
processing and termination factors [3, 127, 136, 150, 251]. However, our genome-wide ChIP-chip data
of Ser2-phosphorylated CTD (Section 6.10; Figure 13B) argues against a role of Ser2 phosphorylation
in triggering the 3´ transition. On the one hand, peak levels of Ser2 phosphorylation are always
reached 6001,000 bp downstream of the TSS, regardless of the position of the pA site. And on
the other hand, recruitment of Pcf11, a 3´-end processing and termination factor that binds the
Ser2-phosphorylated CTD in vitro, is restricted to the pA site. Thus, late Pcf11 entry suggests CTD
masking within the transcribed region.
Here we extended our ChIP-chip proﬁling using a novel monoclonal antibody against the Tyr1-
phosphorylated CTD (3D12, Table 10). Moreover, we determined genome-wide occupancy proﬁles
for termination factors Nrd1, Rtt103, and Pcf11, which contain a CTD-interacting domain (CID).
We show that Tyr1 phosphorylation levels rise downstream of the TSS and decrease upstream of
the pA site, coinciding with recruitment of transcription termination factors. This indicated that
Tyr1 phosphorylation might impair CTD binding of termination factors before the pA site and
suggested a role for Tyr1 dephosphorylation in triggering the 3´ transition. We further found that
Tyr1 phosphorylation indeed impairs recruitment of termination factors Nrd1, Pcf11, and Rtt103
in vitro. Moreover, we show that the Glc7 phosphatase subunit of the cleavage and polyadenylation
factor (CPF) is required for Tyr1 dephosphorylation at the pA site and Pol II termination in vivo.
Taken together these results show that CTD modiﬁcations trigger and block factor recruitment
and lead to an extended CTD code that explains transcription cycle coordination on the basis of
diﬀerential phosphorylation of Tyr1, Ser2, and Ser5.
8.1 Genome-associated Pol II is phosphorylated at Tyr1
To investigate whether genome-associated Pol II is phosphorylated at Tyr1, we used high-resolution
chromatin immunoprecipitation (ChIP) proﬁling in proliferating yeast (Sections 5.6 and 5.7).
Data from two biological replicates (R = 0.94) were averaged and revealed strong signals over
protein-coding and snoRNA genes. To test whether Tyr1 phosphorylation occurs on all transcribed
protein-coding genes, we measured covariation in ChIP data for other CTD phosphorylations by
singular value decomposition (Section 5.7.6). The ﬁrst singular vector explained 83.8% of the
variance (Figure 24), indicating a similar occurrence of phosphorylations at Tyr1, Ser2, and Ser5.
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Figure 24: CTD Tyr1 phosphorylation, like Ser2 and Ser5 phosphorylation, is a general type of CTD
modiﬁcation. (A) Singular value decomposition (SVD) analysis (Section 5.7.6) of Tyr1-P, Ser2-P, and Ser5-P
genome-wide levels. The contributions of the ﬁrst three singular vectors to the variance (red) are shown in
comparison to a control with randomly permuted matrix elements (gray). SVD reveals that 83.8% of the
variance is explained by covariation. (B) Coeﬃcients of ﬁrst left singular vector for the SVD of the occupancy
matrix for the three Pol II phospho-isoforms. The ﬁrst eigenvector with its similar-sized coeﬃcients describes
the co-variation of all three Pol II phospho-isoforms.
Figure 25: CTD Tyr1 phosphorylation levels correlate with mRNA expression in proliferating yeast.
(A) Correlation analysis between the logarithm of the average Tyr1-P levels and the logarithm of mRNA
levels [46]. (B) Gene-averaged proﬁles for genes in three diﬀerent mRNA expression level classes. The
genes were partitioned into three groups: low (25-50% quantile), medium (50-75% quantile) and high (>75%
quantile) expression. From this set of genes, those with ORF lengths between 938 and 1538 were selected.
A correlation between levels of Tyr1 phosphorylation and mRNA expression (Figure 25), further
indicated that Tyr1 phosphorylation is functionally relevant.
Gene-averaging of ChIP proﬁles (Section 5.7.3) revealed Tyr1 phosphorylation in the coding
region (Figure 26A and B). Whereas Tyr1 phosphorylation signals were low at promoters,
they increased downstream of the TSS. The gene-averaged proﬁle resembled that for Ser2
phosphorylation, except that Ser2 phosphorylation signals persist downstream of the pA site for
∼200 bp, whereas Tyr1 phosphorylation signals decrease already around 180 bp upstream of the
pA site (Figure 26B and D). The point of Tyr1 phosphorylation signal increase was dependent on
the TSS, whereas the point of decrease was dependent on the pA site, but not on gene length or
expression level (Figures 25B and 26D). These results indicate that Tyr1 phosphorylation marks are
set and removed within the transcription cycle.
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Figure 26: Gene-averaged ChIP-chip proﬁles for
CTD phosphorylations and termination factors.
(A) DNA frame with promoter, 5´-untranslated
region (UTR), open reading frame (ORF), and
3´-UTR. Dashed black lines indicate the TSS and
pA site. The dashed gray line marks the position
180 bp upstream of the pA site. (B) Gene-
averaged proﬁles for Ser5, Ser2, and Tyr1 phos-
phorylation for 339 genes of `medium/M' length
(1,238 ± 300 bp). (C) Gene-averaged proﬁles for
Nrd1, Pcf11, and Rtt103. ChIP-chip occupancy
of Nrd1 and Rtt103 is on the left y axis, Pcf11
occupancy on the right y axis. (D) Gene-averaged
Tyr1 phosphorylation ChIP proﬁles for `small/S'
(725 ± 213 bp, 266 genes), `medium/M' (B), and
`long/L' (2,217 ± 679 bp, 299 genes) gene length
classes, aligned at the pA site.
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Figure 27: Genome-wide ChIP occupancy
proﬁling of CFI subunits in yeast.
Gene-averaged proﬁles for the long gene-length
class L (2,217 ± 679 bp, 299 genes) for
Pcf11 (Section 6.2), Rna14, and Rna15. Proﬁles
of other length classes are generally similar [147].
Dashed black lines indicate the TSS and pA site.
8.2 Genome-wide occupancy proﬁling of termination factors
8.2.1 CID-containing termination factors
To investigate whether Tyr1 phosphorylation inﬂuences factor recruitment to Pol II, we determined
genome-wide occupancy proﬁles for termination factors Nrd1, Rtt103, and Pcf11, which contain
a CTD-interacting domain (CID). The gene-averaged Nrd1 occupancy peaked at the beginning of
the transcribed region, 193 ± 44 bp downstream of the TSS (Figure 26C). This region also showed
maximum signals in Ser5 phosphorylation, and genomic Nrd1 and Ser5 phosphorylation proﬁles
correlate (R = 0.6), consistent with Nrd1 binding to the Ser5-phosphorylated CTD [224]. The
general presence of Nrd1 at protein-coding genes extends previous results [38, 106] and beﬁts a
role of Nrd1 in early transcription termination [19, 107, 191, 210]. Rtt103 showed peak occupancy
at the end of genes, 112 ± 27 bp downstream of the pA site, where peak levels of Pcf11 were
also observed (Figure 26C). Since this region shows the maximum diﬀerence between Ser2 and
Tyr1 phosphorylation signals, Tyr1 phosphorylation may impair recruitment of Rtt103 and Pcf11
upstream of the pA site. Consistent with this, genome-wide occupancies of Rtt103 and Pcf11 do not
correlate well with Ser2 phosphorylation signals (R = 0.4, for both), although both proteins bind
the Ser2-phosphorylated CTD [136, 150].
8.2.2 Other termination factors
To investigate whether non CID-containing termination factors show a similar binding proﬁle, we
performed ChIP-chip for Rna14 and Rna15. These two proteins are components of the yeast cleavage
factor I (CFI) that also contains Pcf11. This analysis revealed CFI recruitment at all protein-coding
genes that are occupied by Pol II and its elongation factors (Section 6). The gene-averaged ChIP-
chip proﬁles showed sharp occupancy peaks for Rna14 and Rna15, ∼100 bp downstream of the
pA site (Figure 27). These proﬁles were independent of gene length and expression level [147].
Comparison with previous proﬁles (Section 6.2) revealed that the peak occupancies of non CID-
containing Rna14 and Rna15 coincided with CID-containing Pcf11 occupancy, which peaked ∼60 bp
downstream of the pA site (Figure 27 and Table 16).
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8.3 Tyr1 phosphorylation impairs CTD binding of termination but not
elongation factors
Gene-averaged occupancy proﬁles of CID-containing termination factors indicated that Tyr1
phosphorylation might impair CTD binding (Figure 26). To test whether Tyr1 phosphorylation
impairs CTD binding of termination factors in vitro, Andreas Mayer determined the aﬃnity
of puriﬁed recombinant CIDs of yeast Nrd1, Pcf11, and Rtt103 for various CTD diheptad
phosphopeptides using ﬂuorescence anisotropy [145]. Consistent with previous results [136, 224],
Pcf11-CID and Rtt103-CID bound to the Ser2-phosphorylated CTD, whereas the Nrd1-CID
preferentially bound to a Ser5-phosphorylated CTD peptide. In contrast, none of the CIDs bound
Tyr1-phosphorylated CTD peptides, regardless of whether additional phosphorylations were present
or not. Thus Tyr1 phosphorylation blocks CID binding to the CTD in vitro, consistent with the
hypothesis that it impairs termination factor recruitment in vivo.
Elongation factor Spt6 contains a tandem SH2 domain that also binds the CTD. This domain
binds the Ser2-phosphorylated CTD [31, 49, 131, 213] and is required for high Spt6 occupancy
on transcribed genes (Section 6.7), suggesting that Tyr1 phosphorylation does not interfere with
its CTD binding. Indeed the recombinant domain (residues 1250-1444) bound very well to CTD
peptides phosphorylated at Tyr1, Tyr1 and Ser2, or Tyr1 and Ser5, but not to unphosphorylated
CTD [145]. These results were consistent with recent data [31, 49] and showed that interactions with
Tyr1-phosphorylated CTD peptides were even stronger than for peptides with phosphorylations at
Ser2 or Ser5 alone. This shows that Tyr1 phosphorylation stimulates CTD binding of a bona ﬁde
elongation factor, whereas it blocks binding of CID-containing termination factors.
8.4 Glc7 dephosphorylates Tyr1
Our results show that the transition from transcription elongation to termination involves CTD Tyr1
dephosphorylation by an unknown Tyr1 phosphatase (Section 8.3 and Figure 26). We reasoned that
the Tyr1 phosphatase could be part of the large mRNA 3´ processing and termination machinery.
In particular, two of the ﬁfteen subunits of cleavage and polyadenylation factor (CPF), Ssu72 [116,
152] and Glc7 [161], are candidate phosphatases. Ssu72 is known to dephosphorylate CTD residue
Ser5 [9, 116, 241], whereas Glc7 has no known CTD-related activity.
Amelie Schreieck and Stefanie Etzold in collaboration with the group of Lori Passmore could show
that Glc7 dephosphorylates Tyr1 in vitro (manuscript submitted). To investigate whether Glc7 acts
as a CTD Tyr1 phosphatase also in vivo, we depleted Glc7 from the nucleus using the anchor-away
method [76] and monitored changes in genome-wide occupancy with Tyr1-phosphorylated Pol II
by chromatin immunoprecipitation proﬁling (Sections 5.6 and 5.7). For metagene analysis of ChIP
data, we aligned genes at their pA sites [159] and excluded genes ﬂanked by a neighboring gene
within 400 bp downstream of their pA site. Glc7 nuclear depletion led to a strong defect in Tyr1
dephosphorylation at pA sites (Figure 28A). Defective Tyr1 dephosphorylation was not due to
rapamycin treatment that is used in the anchor-away procedure (Figure 28B). Additional ChIP data
indicated that Glc7 is required for transcription termination. The ChIP signal for total Pol II (Rpb3
subunit) normally decreased about 200 bp downstream of the pA site, indicating transcription
termination and Pol II release from DNA (Figure 28C, −Rapa). However, upon nuclear depletion
of Glc7, strong Pol II ChIP signals remained further downstream (Figure 28C, +Rapa). These data
show that Glc7 acts globally and is required for eﬀective CTD Tyr1 dephosphorylation and normal
transcription termination in vivo.
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Figure 28: Glc7 is required for Tyr1 dephosphorylation and transcription termination in vivo.
(A, B) Metagene analysis for genome-wide ChIP occupancy of Tyr1-phosphorylated Pol II around pA sites
in the Glc7-FRB anchor-away strain (A) and in the anchor-away wild-type strain (B). 619 genes were
aligned at the pA site (Section 5.7.3). (A) Occupancy for Tyr1-phosphorylated Pol II decreases sharply
at the pA site (−Rapa, violet line), but Glc7 depletion largely abolishes this decrease (+Rapa, violet dotted
line). (B) Rapamycin treatment has no eﬀect on Tyr1-phosphorylated Pol II occupancy in the anchor-away
wild-type strain (compare −Rapa, violet line and +Rapa, violet dotted line). (C) Metagene analysis as in A
but for total Pol II (subunit Rpb3). Occupancy of Pol II normally decreases downstream of the pA site,
indicating transcription termination (−Rapa, black line). Nuclear depletion of Glc7 impairs termination
(+Rapa, black dotted line). (D) Model for the Pol II elongation-termination transition. DNA and RNA are
depicted as gray lines, Pol II and its CTD are in black. For details see text.
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Figure 29: Extended CTD code for transcription cycle coordination. During the cycle, levels of CTD
phosphorylation at Tyr1, Ser2, and Ser5 residues change diﬀerently, as illustrated by color gradients.
8.5 Discussion & Summary
Our results extend the previously proposed CTD code [18, 33, 51] (for details see Section 1.2.1),
leading to an extended CTD code for the coordination of the transcription cycle with factor
recruitment (Figure 29), and a new model for the elongation-termination transition of Pol II at
the 3´-ends of protein-coding genes (Figure 28D).
During initiation and early elongation, the CTD is phosphorylated on Ser5, which facilitates
recruitment of the capping enzyme and Nrd1. 150-200 bp downstream of the TSS, peak occupancy
levels are reached for Nrd1 and Pol II, likely marking a decision point where Pol II transiently
pauses and either terminates or continues elongation [19]. When Tyr1 and Ser2 phosphorylation
levels rise, Pol II binds elongation factors stably and continues elongation. Tyr1 phosphorylation
releases Nrd1 and impairs recruitment of Rtt103 and Pcf11, thereby suppressing termination during
elongation. Our results indicate that Tyr1 CTD phosphorylation is a target to activate transcription
by suppressing Pol II termination, and explain why mutation of Tyr1 to phenylalanine, which lacks
the oxygen atom required for phosphorylation, is lethal [232].
When Pol II reaches the pA site, the Glc7 subunit of CPF dephosphorylates Tyr1, whereas Ser2
phosphorylation remains. This allows for binding of Pcf11 and Rtt103, termination factors that are
not part of CPF and show peak occupancy ∼50-100 bp downstream of the pA site. Transcription
terminates further downstream and releases Pol II from genes (Figure 28D, −Rapa). When Glc7
is depleted from the nucleus, Tyr1 phosphorylation levels remain high downstream of the pA site,
impairing termination factor recruitment and Pol II release (Figure 28D, +Rapa). Our results not
only establish Glc7 as the Pol II CTD Tyr1 phosphatase, but they also unravel CPF-triggered Pol II
dephosphorylation as a key event that couples pA-dependent 3´ RNA processing to transcription
termination.
A link between the pA site and transcription termination was established over 25 years ago [133]. In
the `anti-terminator' model, transcription of the pA site triggers a change in the Pol II machinery
that allows for termination [17, 19, 155]. In the `torpedo' model, pA-dependent RNA cleavage results
in a new RNA 5´-end that is recognized by the Rat1/Rai1/Rtt103 exonuclease complex that degrades
nascent RNA and triggers termination [17, 19, 155]. Our data are consistent with a combination of
both models. Tyr1 phosphorylation serves as an anti-terminator that is released at the pA site by
Glc7 dephosphorylation, which then allows recruitment of the torpedo nuclease complex.
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9 A global view of the RNA polymerase II transcription cycle
In this work we used high-resolution ChIP-chip occupancy proﬁling of the RNA polymerase (Pol) II
transcription machinery to obtain new insights into the mRNA trancription cycle. To integrate
all the data we carried out a correlation analysis using all genome-wide proﬁles reported
here (Sections 6 to 8). Pearson correlation coeﬃcients between proﬁles were provided as a
similarity metric to calculate a correlation-based two-dimensional network using the GraphViz's
Neato algorithm [56] (Figure 30). In the resulting network, elongation factors cluster with Pol II,
indicating that the elongating form of Pol II dominates its occupancy proﬁle. The three groups
of elongation factors observed in Section 6 form sub-groups of the elongation cluster. Initiation
and termination factors form distinct clusters, reﬂecting diﬀerent phases of the transcription cycle.
Proﬁles for the capping enzymes lie between clusters for initiation and elongation factors. This
unbiased analysis highlights the central role of pre-mRNA capping during the initiation-elongation
transition (Section 7). Proﬁles of the Pol II isoforms phosphorylated at Ser5 and Ser7 fall
between the initiation and elongation clusters, consistent with the role of these modiﬁcations in
the transition [41, 114, 149, 199, 209]. Proﬁles of the Pol II isoforms phosphorylated at Tyr1
and Ser2 fall between the elongation and termination clusters, highlighting their role during the
3´ transition (Section 8) [3, 127, 136, 150, 251].
Figure 30: Correlation-based network of occupancy proﬁles reﬂects diﬀerent phases of the transcription
cycle. Correlation analysis of genome-wide ChIP-chip proﬁles reported in Sections 6 to 8. Pairwise Pearson
correlation coeﬃcients were calculated between concatenated gene proﬁles ranging from TSS−250 bp to
pA+250 bp and provided as a similarity metric to calculate a two-dimensional network using the GraphViz's
Neato algorithm (see Methods 5.7.5). Solid lines represent known direct interactions between factors. Dashed
lines represent known direct interactions between factors and the phosphorylated CTD of Pol II. Essential
and non-essential factors are represented as boxes and circles, respectively. Pol II phospho-isoforms are
represented as hexagons.
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Part IV
Future perspectives
Precise coordination of gene expression is essential for proper cell functioning and depends on the
interaction of proteins with DNA. The capability of studying genome-wide occupancy of transcription
factors ([72, 122, 226]), the general RNA polymerase (Pol) II transcription machinery (this work
and [9, 106, 158, 188, 218, 225, 249]), as well as chromatin states and modiﬁcations ([67, 78, 143, 144,
200]), have greatly aided our understanding of global gene regulation. Some of the future challenges
arising from the results presented here are discussed in the following paragraphs:
Mechanisms that modulate the composition of the transcribing Pol II complex
This work started by generating high-resolution genome-wide ChIP occupancy proﬁles of Pol II,
its phosphorylated CTD isoforms, as well as components of the initiation, elongation, termination,
and RNA processing machinery in proliferating S. cerevisiae cells. Statistical data analysis provided
evidence for a general Pol II transcription complex that mediates transcription and mRNA processing
at all actively transcribed Pol II genes. At both ends of genes this complex undergoes uniform
transitions in factor composition (Section 6). We could identify which factors are exchanged during
these transitions, and furthermore determine the precise genomic locations of these events.
The challenge ahead is to completely unravel the molecular mechanisms involved in orchestrating
the composition of the transcribing Pol II complex throughout the transcription cycle.
We started to address this issue by providing evidence that mRNA 5´ cap completion underlies
the initiation-elongation transition and triggers productive Pol II elongation (Section 7), and that
Pol II CTD tyrosine 1 dephosphorylation underlies the elongation-termination transition and triggers
mRNA 3´ processing and termination (Section 8). These observations together with additional data
by other groups [2, 57, 141, 147, 182, 181, 213, 239] provide mechanistic insights into the triggers
involved in driving transcription factor exchange during the 5' and 3' transitions. However, more
research is needed to completely understand the molecular mechanisms involved.
For instance, it remains to be fully understood how the main CTD Ser2 kinase Ctk1 associates
with Pol II during the initiation-elongation transition. Although we could show that the cap
methyltransferase Abd1 and the cap-binding complex (CBC) contribute to Ctk1 recruitment, these
factors alone cannot explain the entire Ctk1 occupancy along genes (Section 7). Moreover, elongation
factor Spt6, which is known to bind the phosphorylated CTD in vitro [145], is still partly recruited
to the transcribing polymerase when its CTD interaction domain is deleted (Section 6). Thus,
additional recruitment mechanisms must exist to ensure proper association of these factors with
Pol II.
Emerging roles of the Spt5 CTR and its phosphorylation
It has become apparent that not only the Pol II CTD but also the Spt5 CTR plays an important
role as a platform to recruit accessory factors to the transcribing Pol II complex. As it is the case
for the CTD, factor recruitment by the CTR also occurs in coordination with the transcription
and RNA processing cycle. The Spt5 CTR contributes to capping enzyme recruitment (Section 7),
Paf1 recruitment [132], and cleavage factor I recruitment [147], during early elongation, productive
elongation, and termination, respectively. Considering that the CTR can be phosphorylated by
Bur1 [132, 254], and since our data suggest that this phosphorylation of the CTR might release
capping enzymes from Spt5, it will be fascinating to study the role of the phosphorylation state
of the CTR in factor recruitment in coordination with the transcription cycle. Similar to the
proposed CTD code (Section 1.2.1) the changing phosphorylation status of the CTR during
the transcription cycle could allow binding of diﬀerent transcription and RNA processing factors
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in an ordered manner. Experimentally this could be addressed by generating an antibody that
speciﬁcally recognizes the phospho-CTR. Such an antibody could then be used to perform ChIP
experiments revealing possible changes in CTR phosphorylation during the transcription cycle.
Moreover, correlation analysis between phosphorylation level and factor occupancies could provide
insights about the phosphorylation state of the CTR in known protein-CTR interactions and also
contribute to the identiﬁcation of novel CTR binders. In addition, an unbiased approach to identify
novel CTR binders would be to combine an aﬃnity-puriﬁcation assay with mass spectrometry (MS).
Novel and additional roles of CTD modiﬁcations
For various CTD phospho-modiﬁcations there are now highly speciﬁc antibodies available, which
allowed us to investigate the genome-wide distribution of these marks (Sections 6 and 8).
Correlation analysis between genome-wide phosphorylation levels and occupancy of proteins known
to bind to the phosphorylated CTD in vitro, revealed that the in vivo situation of CTD binding
might be more complex than initially thought. For instance, based on the ChIP proﬁles observed
for CTD phosphorylation marks and CTD-interacting termination factors, we hypothesized and
veriﬁed in the lab that Tyr1-P impairs binding of these termination factors to the CTD during the
elongation phase of transcription (Section 8, [145]). Thus, Tyr1-P is used to ﬁne-tune the binding of
termination factors to the Ser5-P and Ser2-P CTD. It will be interesting to see whether additional
mechanisms exist that allow ﬁne-tuning of the CTD code.
Tyr1-P could also modulate the binding of the capping enzymes Cet1-Ceg1 to the Ser5-P CTD, since
Cet1-Ceg1 is released from the CTD prior to Ser5 dephosphorylation (Section 7) and the ChIP-chip
proﬁles of Cet1-Ceg1 occupancy and Tyr1-P levels are mutually exclusive (Sections 7 and 8). One
way to investigate this further would be to determine the in vitro aﬃnity of puriﬁed recombinant
Cet1-Ceg1 for CTD diheptad phosphopeptides (Ser5-P vs. Tyr1-P+Ser5-P) by using ﬂuorescence
anisotropy [145]. Additionally, once the Tyr1 kinase has been identiﬁed, ChIP experiments could
be used to investigate what eﬀect conditional depletion of the kinase has on Cet1-Ceg1 release in vivo.
Although the genome-wide proﬁle of Ser7-P has been mapped (Section 6) and its kinase
discovered [4], its function at protein coding genes remains unclear and has to be investigated. Since
the Ser7-P proﬁle correlates well with occupancy of the capping enzymes (Sections 6 and 7), one
could imagine a role in recruiting capping enzymes in addition to Ser5-P or stimulation of capping.
Furthermore, the functions and binders of Thr4-P in yeast as well as of other CTD modiﬁcations like
glycosylations need to be investigated. Future advances in the development of in vivo cross-linking
technologies coupled with MS approaches might be of use to determine the complete set of CTD
binding proteins and to eventually understand how they coordinately interact with the CTD to
regulate transcription and/or RNA processing.
Identiﬁcation of missing CTD kinases and phosphatases
We obtained genome-wide levels of all possible CTD phosphorylations (Sections 6 and 8),
however, the yeast kinases and the phosphatase required for Tyr1/Thr4 phosphorylation and Thr4
dephosphorylation, respectively, remain to be identiﬁed. One way to ﬁnd respective kinase(s) and
phosphatase(s) in vivo would be to conditionally deplete potential candidates and observe whether
the Tyr1/Thr4 phosphorylation level is altered by ChIP experiments. Conditional nuclear depletion
of the factors of interest can be achieved by using the anchor-away technique (Section 7, [76]).
Moreover, kinases can also be identiﬁed by the use of analog-sensitive yeast strains [14]. Furthermore,
in vitro phosphatase assays with puriﬁed phosphatases and Thr4 phosphorylated CTD as substrates
could contribute to the identiﬁcation of the phosphatases.
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Analysis of the CTD by mass spectrometry
One current limitation of CTD research is that most knowledge relies on the use of monoclonal
antibodies that speciﬁcally recognize certain modiﬁed CTD residues. Binding of these antibodies
requires that the epitopes are accessible, which is often prevented by neighboring modiﬁcations.
Moreover, these antibodies cannot distinguish on which individual repeat a certain mark is present
along the linear CTD. To circumvent some of the limitations imposed by using antibodies, the
challenge ahead will be to use novel MS approaches to decipher the CTD state. Since the lack
of positively charged amino acids makes the phospho-CTD patterns diﬃcult to read out via MS,
genetically engineered CTDs could be designed to facilitate proper MS analysis [77]. This would
allow a more direct observation of the CTD modiﬁcation status (i.e. which modiﬁcations occur, in
which combinations, in which parts of the CTD).
The role of nascent RNA in recruiting Pol II associated factors
The nascent RNA adds an additional layer of complexity to the assembly/disassembly events of the
transcribing Pol II complex. It has been shown for some transcription and RNA processing factors
that they can bind the nascent RNA [38, 47, 147, 170, 175], and for some it was demonstrated
that they are (at least partially) recruited to the transcription machinery in an RNA dependent
manner [47, 147]. Thus, the nascent RNA can also contribute to modulate the factor composition
of the transcribing Pol II complex. In the work presented here we used ChIP to investigate the
interactions of the Pol II machinery with DNA. To further complement the resulting occupancy data,
it would be beneﬁcial to investigate whether and if so how, the Pol II machinery interacts with nascent
RNA during the transcription cycle. PAR-CLIP, a novel method to identify transcriptome-wide
protein-RNA interactions in vivo [70], can be used to address this issue.
Controlling of pervasive transcription
The use of tiling microarrays and, more recently, RNA sequencing for studying trancriptomes has
led to the dicovery that most of the DNA of eukaryotic genomes is transcribed by Pol II [89]. This
pervasive transcription gives rise to a wealth of novel non-coding and potentially non-functional RNA
species, and implies a requirement for massive RNA quality surveillance in the nucleus. Despite
the question to what extent these novel transcripts (or their synthesis per se) are biologically
functional [228], or whether the majority simply accounts for transcriptional noise [211], another
future challenge is to unravel the underlying molecular mechanisms that are employed to distinguish
functional from non-functional RNAs and degrade the latter.
In yeast, cryptic unstable transcripts (CUTs) are likely to be enriched for RNA binding motifs
that are recognized by the Nrd1Nab3Sen1 complex, which usually facilitates termination of
sno/snRNAs [38, 217]. This complex can also induce termination of CUT transcription and
couples it to degradation by the nuclear exosome. A comparable mechanism in higher eukaryotes
remains to be identiﬁed, and it is likely that additional characteristics exist to distinguish the
products of pervasive transcription from stable RNAs, including chromatin modiﬁcations or the
status/composition of the transcribing Pol II complex. A combination of genome-wide ChIP,
PAR-CLIP, as well as nascent RNA sequencing experiments under various conditions will be needed
to further address these questions and elucidate the underlying mechanisms.
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